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Abstract
In this chapter, we present econometric and statistical methods for analyzing ran-
domized experiments. For basic experiments we stress randomization-based inference as
opposed to sampling-based inference. In randomization-based inference, uncertainty in es-
timates arises naturally from the random assignment of the treatments, rather than from
hypothesized sampling from a large population. We show how this perspective relates
to regression analyses for randomized experiments. We discuss the analyses of stratified,
paired, and clustered randomized experiments, and we stress the general efficiency gains
from stratification. We also discuss complications in randomized experiments such as non-
compliance. In the presence of non-compliance we contrast intention-to-treat analyses with
instrumental variables analyses allowing for general treatment effect heterogeneity. We con-
sider in detail estimation and inference for heterogenous treatment effects in settings with
(possibly many) covariates. These methods allow researchers to explore heterogeneity by
identifying subpopulations with different treatment effects while maintaining the ability
to construct valid confidence intervals. We also discuss optimal assignment to treatment
based on covariates in such settings. Finally, we discuss estimation and inference in exper-
iments in settings with interactions between units, both in general network settings and
in settings where the population is partitioned into groups with all interactions contained
within these groups.
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1 Introduction
Randomized experiments have a long tradition in agricultural and biomedical settings. In eco-
nomics they have a much shorter history. Although there have been notable experiments over
the years, such as the RAND health care experiment (Manning, Newhouse, Duan, Keeler and
Leibowitz, 1987, see the general discussion in Rothstein and von Wachter, 2016) and the Neg-
ative Income Tax experiments (e.g., Robins, 1985), it is only recently that there has been a
large number of randomized experiments in economics, and development economics in particu-
lar. See Duflo, Glennerster, and Kremer (2006) for a survey. As digitization lowers the cost of
conducting experiments, we may expect that their use may increase further in the near future.
In this chapter we discuss some of the statistical methods that are important for the analysis
and design of randomized experiments.
Although randomized experiments avoid many of the challenges of observational studies
for causal inference, there remain a number of statistical issues to address in the design and
analysis of experiments. Even in the simplest case with observably homogenous, independent
subjects, where the experiment is evaluated by comparing sample means for the treatment and
control group, there are questions of how to conduct inference about the treatment effect. When
there are observable differences in characteristics among units, questions arise about how best
to design the experiment and how to account for imbalances in characteristics between the
treatment and control group in analysis. In addition, it may be desirable to understand how
the results of an experiment would generalize to different settings. One approach to this is to
estimate heterogeneity in treatment effects; another is to reweight units according to a target
distribution of characteristics. Finally, statistical issues arise when units are not independent,
as when they are connected in a network. In this chapter, we discuss a variety of methods for
addressing these and other issues.
A major theme of the chapter is that we recommend using statistical methods that are di-
rectly justified by randomization, in contrast to the more traditional sampling-based approach
that is commonly used in econometrics. In essence, the sampling based approach considers the
treatment assignments to be fixed, while the outomes are random. Inference is based on the
idea that the subjects are a random sample from a much larger population. In contrast, the
randomization-based approach takes the subject’s potential outcomes (that is, the outcomes
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they would have had in each possible treatment regime) as fixed, and considers the assignment
of subjects to treatments as random. Our focus on randomization follows the spirit of Freedman
(2006, p. 691), who wrote: “Experiments should be analyzed as experiments, not as observa-
tional studies. A simple comparison of rates might be just the right tool, with little value added
by ‘sophisticated’ models.” Young (2016) has recently applied randomization-based methods in
development economics.
As an example of how the randomization-based approach matters in practice, we show that
methods that might seem natural to economists in the conventional sampling paradigm (such as
controlling for observable heterogeneity using a regression model) require additional assumptions
in order to be justified. Using the randomization-based approach suggests alternative methods,
such as placing the data into strata according to covariates, analyzing the within-group exper-
iments, and averaging the results. This is directly justified by randomization of the treatment
assignment, and does not require any additional assumptions.
Our overall goal in this chapter is to collect in one place some of the most important statis-
tical methods for analyzing and designing randomized experiments. We will start by discussing
some general aspects of randomized experiments, and why they are widely viewed as providing
the most credible evidence on causal effects. We will then present a brief introduction to causal
inference based on the potential outcome perspective. Next we discuss the analysis of the most
basic of randomized experiments, what we call completely randomized experiments where, out of
a population of size N , a set of Nt units are selected randomly to receive one treatment and the
remaining Nc = N−Nt are assigned to the control group. We discuss estimation of, and inference
for, average as well as quantile treatment effects. Throughout we stress randomization-based
rather than model-based inference as the basis of understanding inference in randomized experi-
ments. We discuss how randomization-based methods relate to more commonly used regression
analyses, and why we think the emphasis on randomization-based inference is important. We
then discuss the design of experiments, first considering power analyses and then turning to
the benefits and costs of stratification and pairwise randomization, as well as the complications
from re-randomization. We recommend using experimental design rather than analysis to ad-
just for covariates differences in experiments. Specifically, we recommend researchers to stratify
the population into small strata and then randomize within the strata and adjust the standard
errors to capture the gains from the stratification. We argue that this approach is preferred
[2]
to model-based analyses applied after the randomization to adjust for differences in covariates.
However, there are limits on how small the strata should be: we do not recommend to go as far
as pairing the units, because it complicates the analysis due to the fact that variances cannot
be estimated within pairs, whereas they can within strata with at least two treated and two
control units. We also discuss in detail methods for estimating heterogenous treatment effects.
We focus on methods that allow the researcher to identify subpopulations with different average
treatment effects, as well as methods for estimating conditional average treatment effects. In
both cases these methods allow the researcher to construct valid confidence intervals.
This chapter draws from a variety of literatures, including the statistical literature on the
analysis and design of experiments, e.g., Wu and Hamada (2009), Cox and Reid (2000), Altman
(1991), Cook and DeMets (2008), Kempthorne (1952, 1955), Cochran and Cox (1957), Davies
(1954), and Hinkelman and Kempthorne (2005, 2008). We also draw on the literature on
causal inference, both in experimental and observational settings, Rosenbaum (1995, 2002, 2009),
Rubin (2006), Cox (1992), Morgan and Winship (2007), Morton Williams (2010) and Lee (2005),
and Imbens and Rubin (2015). In the economics literature we build on recent guides to practice
in randomized experiments in development economics, e.g., Duflo, Glennerster, and Kremer
(2006), Glennerster (2016), and Glennerster and Takavarasha (2013) as well as the general
empirical micro literature (Angrist and Pischke, 2008).
There have been a variety of excellent surveys of methodology for experiments in recent years.
Compared to Duflo, Glennerster and Kremer (2006), Glennerster and Takavarasha (2013) and
Glennerster (2016), this chapter focuses more on formal statistical methods and less on issues
of implementation in the field. Compared to the statistics literature, we restrict our discussion
largely to the case with a single binary treatment. We also pay more attention to the compli-
cations arising from non-compliance, clustered randomization, and the presence of interactions
and spillovers. Relative to the general causal literature, e.g., Rosenbaum (1995, 2009) and
Imbens and Rubin (2015), we do not discuss observational studies with unconfoundedness or
selection-on-observables in depth, and focus more on complications in experimental settings.
This chapter is organized as follows. In Section 8 we discuss the complications arising from
cluster-level randomization. We discuss how the use of clustering required the researcher to make
choices regarding the estimands. We also focus on the choice concerning the unit of analysis,
clusters or lower-level units. We recommend in general to focus on cluster-level analyses as the
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primary analyses. Section 9 contains a discussion of non-compliance to treatment assignment and
its relation to instrumental variables methods. In Section 10 we present some recent results for
analyzing heterogeneity in treatment effects. Finally, Section 11 we discuss violations of the no-
interaction assumption, allowing outcomes for one unit to be affected by treatment assignments
for other units. These interactions can take many forms, some through clusters, and some
through general networks. We show that it is possible to calculate exact p-values for tests of
null hypotheses of no interactions while allowing for direct effects of the treatments. Section 12
concludes.
2 Randomized Experiments and Validity
In this section we discuss some general issues related to the interpretation of analyses of ran-
domized experiments and their validity. Following Cochran (1972, 2015) we define randomized
experiments as settings where the the assignment mechanism does not depend on characteristics
of the units, either observed or unobserved, and the researcher has control over the assignments.
In contrast, in observational studies (Rosenbaum, 1995; Imbens and Rubin, 2015), the researcher
does not have control over the assignment mechanism, and the assignment mechanism may de-
pend on observed and or unobserved characteristics of the units in the study. In this section we
discuss four specific issues. First, we elaborate on the distinction between randomized experi-
ments and observational studies. Second, we discuss internal validity, and third, external valid-
ity. Finally, we discuss the issues related to finite population versus infinite super-population
inference.
2.1 Randomized Experiments versus Observational Studies
There is a long tradition viewing randomized experiments as the most credible of designs to
obtain causal inferences. Freedman (2006) writes succintly “Experiments offer more reliable
evidence on causation than observational studies.” On the other hand, some researchers continue
to be skeptical about the relative merits of randomized experiments. For example, Deaton
(2010) argues, that “I argue that evidence from randomized experiments has no special priority.
... Randomized experiments cannot automatically trump other evidence, they do not occupy
any special place in some hierarchy of evidence” (Deaton, p. 426). Our view aligns with
[4]
that of Freedman and others who view randomized experiments as playing a special role in
causal inference. A randomized experiment is unique in the control the researcher has over the
assignment mechanism, and by virtue of that control, selection bias in comparisons between
treated and control units can be eliminated. That does not mean that randomized experiments
can answer all causal questions. There are a number of reasons why randomized experiments
may not be suitable to answer particular questions.
First, consider a case where we are interested in the causal effect of a particular intervention
on a single unit: what would the outcome have been for a particular firm in the absence of
a merger compared to the outcome given the merger. In that case, and similarly for many
questions in macroeconomics, no randomized experiment will provide us with the answer to
the causal question. Once the interest is in an intervention that can be applied repeatedly,
however, it may be possible to conduct experiments, or find data from quasi experiments, even
in macroeconomics. Angrist and Kuersteiner (2011), building on work by Romer and Romer
(2004), use the potential outcome framework to discuss causal analyses in a macro-economic
time series context. Second, it may not be ethical to conduct an experiment. In educational
settings it is often impossible to withhold particular educational services to individuals in order
to evaluate their benefits. In such cases one may need to do observational studies of some kind,
possibly randomizing inducements to participate in the programs.
2.2 Internal Validity
In a classic text, Shadish, Cook, and Campbell (2002) discuss various aspects of the validity of
studies of causal effects. Here we focus on two of the most important ones, internal validity and
external validity. Shadish, Cook, and Campbell (2002) define a study to have internal validity if
the observed covariance between a treatment and an outcome reflects “a causal relationship ... in
which the variables were manipulated,” (p. 53). Internal validity refers to the ability of a study
to estimate causal effects within the study population. Shadish, Cook, and Campbell (2002) then
continue to observe that “the [internal validity] problem is easily solved in experiments because
they force the manipulation of A to come before the the measurement of B.” Essentially they
argue that well-executed randomized experiments by definition have internal validity, and that
the problem of internal validity is one that plagues only observational studies or compromised
random experiments. This is not necessarily true in experimental settings where interference
[5]
between units is a concern.
2.3 External Validity
The second aspect of validity that Shadish, Cook, and Campbell (2002) consider is that of
external validity. They write that “external validity concerns inferences about the extent to
which a causal relationship holds over variation in persons, settings, treatments, and outcomes.”
(p 83). Thus, external validity is concerned with generalizing causal inferences, drawn for
a particular population and setting, to others, where these alternative settings could involve
different populations, different outcomes, or different contexts.
Shadish, Cook and Campbell argue for the primacy of internal validity, and claim that
without internal validity causal studies have little value. This echos Neyman’s comment that
without actual randomization a study would have little value, as well as Fisher’s observation
that randomization was what he called “the reasoned basis” for inference. It stands in sharp
contrast with a few researchers who have recently claimed that there is no particular priority
for internal validity over external validity (e.g., Manski, 2013).
The first important point is that external validity cannot be guaranteed, neither in ran-
domized experiments, nor in observational studies. Formally one major reason for that in
experiments involving human subjects is that one typically needs informed consent: individuals
typically need to agree to participate in the experiment. There is nothing that will guarantee
that subjects who agree to do so will be similar to those that do not do so, and thus there is noth-
ing that can guarantee that inferences for populations that give informed consent will generalize
to populations that do not. See also the discussion in Glennerster (2016). This argument has
been used to question the value of randomized experiments. However, as Deaton (2010) notes,
the same concern holds for nonexperimental studies: “RCTs, like nonexperimental results, can-
not automatically be extrapolated outside the context in which they were obtained” (Deaton,
2010, p. 449). There is nothing in non-experimental methods that makes them superior to
randomized experiments with the same population and sample size in this regard.
Fundamentally, most concerns with external validity are related to treatment effect hetero-
geneity. Suppose one carries out a randomized experiment in setting A, where the setting may
be defined in terms of geographic location, or time, or subpopulation. What value have infer-
ences about the causal effect in this location regarding the causal effect in a second location,
[6]
say setting B. Units in the two settings may differ in observed or unobserved characteristics, or
treatments may differ in some aspect. To assess these issues it is helpful to have causal studies,
preferably randomized experiments, in multiple settings. These settings should vary in terms
of the distribution of characteristics of the units, and possibly in terms of the specific nature of
the treatments or the treatment rate, in order to assess the credibility of generalizing to other
settings. An interesting case study is the effect of micro finance programs. Meager (2015) ana-
lyzes data from seven randomized experiments, including six published in a special issue of the
American Economic Journal (Applied) in 2015, and finds remarkable consistency across these
studies.
Another approach is to specifically account for differences in the distributions of character-
istics across settings. Hotz, Imbens, Mortimer (2005) and Imbens (2010) set up a theoretical
framework where the differences in treatment effects between locations arise from differences
in the distributions of characteristics of the units in the locations. Adjusting for these dif-
ferences in unit-level characteristics (by reweighting the units) enables the researcher to com-
pare the treatment effects in different locations. Allcott (2015) assess the ability of similar
unconfoundedness/selection-on-observable conditions to eliminate differences in treatment ef-
fects between 111 energy conservation programs. Recently developed methods for assessing
treatment effect heterogeneity with respect to observables, reviewed below in Section 10, can in
principle be used to flexibly estimate and conduct inference about treatment effects conditional
on observables.
Finally, Bareinboim, Lee, Honavar and Pearl (2013) develop graphical methods to deal with
external validity issues.
2.4 Finite Population versus Random Sample from Super-population
It is common in empirical analyses to view the sample analyzed as a random sample drawn
randomly from a large, essentially infinite super-population. Uncertainty is viewed as arising
from this sampling, with knowledge of the full population leading to full knowledge of the
estimands. In some cases, however, this is an awkward perspective. In some of these cases the
researcher observes all units in the entire population, and sampling uncertainty is absent. In
other cases it is not clear what population the sample can be viewed as being drawn from.
A key insight is that viewing the statistical problem as one of causal inference allows one
[7]
to interpret the uncertainty as meaningful without any sampling uncertainty. Instead the un-
certainty is viewed as arising from the unobserved (mising) potential outcomes: we view some
units in the population exposed to one level of the treatment, but do not observe what would
have happened to those units had they been exposed to another treatment level, leaving some
of the components of the estimands unobserved. Abadie, Athey, Imbens and Wooldridge (2014)
discuss these issues in detail.
In part of the discussion in this chapter, therefore, we view the sample at hand as the full
population of interest, following the approaches taken by Fisher (1925, 1935), Neyman (1935),
and subsequently by Rubin (1974, 1978, 2007). The estimands are defined in terms of this finite
population. However, these estimands depend on all the potential outcomes, some observed
and others not observed, and as a result we cannot infer the exact values of the estimands even
if all units in the population are observed. Consider an experiment with ten individuals, five
randomly selected to receive a new treatment, and the remaining five assigned to the control
group. Even if this group of ten individuals is the entire population of interest, observing
realized outcomes for these ten individuals will not allow us to derive the estimand, say the
difference in the average outcome if all individuals were treated and the average outcome if all
ten individual were to receive the control treatment, without uncertainty. The uncertainty is
coming from the fact that for each individual we can only see one of the two relevant outcomes.
In many cases the variances associated with estimators based on random assignment of the
treatment will be similar to those calculated conventionally based on sampling uncertainty. In
other cases the conventional sampling-based standard errors will be unnecessarily conservative.
When covariates are close to uncorrelated with the treatment assignment (as in a randomized
experiment), the differences are likely to be modest. See Abadie, Athey, Imbens and Wooldridge
(2014) for details.
3 The Potential Outcome / Rubin Causal Model Frame-
work for Causal Inference
The perspective on causality we take in this chapter is associated with the potential outcome
framework (for a textbook discussion see Imbens and Rubin, 2015). This approach goes back to
Fisher (1925) and Neyman (1928). The work by Rubin (1973, 1975, 1978) led Holland (1986)
[8]
to label it the Rubin Causal Model (RCM).
3.1 Potential Outcomes
This RCM or potential outcome setup has three key features. The first is that it associates causal
effects with potential outcomes. For example, in a setting with a single unit (say an individual),
and a single binary treatment, say taking a drug or not, we associate two potential outcomes with
this individual, one given the drug and one without the drug. The causal effect is the comparison
between these two potential outcomes. The problem, and in fact what Holland (1985) in a widely
quoted phrase called the “fundamental problem of causal inference” (Holland, 1986, p. 947) is
that we can observe at most one of these potential outcomes, the one corresponding to the
treatment received. In order for these potential outcomes to be well defined, we need to be able
to think of a manipulation that would have made it possible to observe the potential outcome
that corresponds to the treatment that was not received, which led Rubin to claim “no causation
without manipulation” (Rubin, 1975, p. 238). Because for any single unit we can observe at
most one of the potential outcomes, we need to observe outcomes for multiple units. This is the
second feature of the potential outcomes framework, the necessity of the presence of multiple
units. By itself the presence of multiple units does not solve the problem because with multiple
units the number of distinct treatments increases: with N units and two treatment levels for each
unit there are 2N different values for the full vector of treatments, with any comparison between
two of them a valid causal effect. However, in many cases we are willing to make assumptions
that interactions between units is limited so that we can draw causal inferences from comparisons
between units. An extreme version of this is the assumption that the treatment for one unit does
not affect outcomes for any other unit, so that there is no interference whatsoever. The third key
feature of the RCM is the central role of the assignment mechanism. Why did a unit receive the
treatment it did receive? Here randomized experiments occupy a special place in the spectrum
of causal studies: in a randomized experiment the assignment mechanism is a known function of
observed characteristics of the units in the study. The alternative, where parts of the assignment
mechanism are unknown, and may possibly depend on unobserved characteristics (including the
potential outcomes) of the units, are referred to as observational studies (Cochran, 1972).
There are alternative approaches to causality. Most notably there has been much work
recently on causal graphs, summarized in the book by Pearl (2000, 2009). In this approach causal
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link are represented by arrows and conditional independencies are captured by the absence of
arrows. These methods have been found useful in studies of identification questions as well as
for using data to discover causal relationships among different variables. However, the claims in
this literature (e.g., Pearl, 2000, 2009) that the concept of a causal effect does not require the
ability to at least conceptually manipulate treatments remains controversial.
Let us now add some specifics to this discussion. Suppose we start with a single unit, say “I”.
Suppose we have a binary treatment, denoted byW ∈ {0, 1} for this unit, which may correspond
to taking a drug or not. The two potential outcomes are Y (0), the outcome for me if I do not
take the drug, and Y (1), the outcome if I do take the drug. The causal effect is a comparison
of the two potential outcomes, say the difference, Y (1) − Y (0), or the ratio, Y (1)/Y (0). Once
we assign the treatment, one of the potential outcomes will be realized and possibly observed:
Y obs = Y (W ) =
{
Y (0) if W = 0,
Y (1) if W = 1
We can only observe one of the potential outcomes, so drawing credible and precise inferences
about the causal effect, say the difference Y (1)−Y (0) is impossible without additional assump-
tions or information. Now let us generalize to the setting with N units, indexed by i = 1, . . . , N .
Each of the units can be exposed to the two treatments, no drug or drug, with Wi denoting the
treatment received for unit i. Let W be the N−vector of assignments with typical element Wi.
The problem is that in principle the potential outcomes can depend on the treatments for all
units, so that for each unit we have 2N different potential outcomes Yi(W ). In many cases it
is reasonable to assume that the potential outcomes for unit i depend solely on the treatment
received by unit i. This is an important restriction on the potential outcomes, and one that is
unrealistic in many settings, with a classic example being that of vaccinations for infectious dis-
eases. For example, exposing some students to educational interventions may affect outcomes
for their class mates, or training some unemployed individuals may affect the labor market
prospects for other individuals in the labor market. We will discuss the complications arising
from interactions in Section 11. Note that the interactions can be a nuisance for estimating the
effects of interest, but they can also be the main focus.
If we are willing to make the no-interference assumption, or sutva (stable unit treatment
value assumption, Rubin, 1978), we can index the potential outcomes by the own treatment
only, and write without ambiguity Yi(w), for w = 0, 1. For each of the N units the realized
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outcome is now Y obsi = Yi(Wi). Now with some units exposed to the active treatment and some
exposed to the control treatment, there is some hope for drawing causal inferences. In order to
do so we need to make assumptions about the assignment mechanism. To be formal, let Y be
the range of values for the potential outcomes, and let X be the range of values for the covariates
or pretreatment variables. In general we write this as a function
p : {0, 1}N × Y2N × XN 7→ [0, 1],
so that p(W |Y (0),Y (1),X) is the probability of the assignment vector W , as a function of all
the potential outcomes and covariates.
We limit the general class of assignment mechanism we consider. The most important limita-
tion is that for randomized experiments we disallow dependence on the potential outcomes, and
we assume that the functional form of the assignment mechanism is known. Analyzing observa-
tional studies where the assignment mechanism depends in potentially complicated ways on the
potential outcomes is often a challenging task, typically relying on controversial assumptions.
3.2 A Classification of Assignment Mechanisms
Let us consider four assignment mechanisms that we will discuss in subsequent sections in this
chapter.
3.2.1 Completely Randomized Experiments
In completely randomized experiment a fixed number of units, say Nt, is drawn at random from
the population of N units to receive the active treatment, with the remaining Nc = N − Nt
assigned to the control group. It satisfies
p(W |Y (0),Y (1),X) =
(
N
Nt
)−1
for all W such that
N∑
i=1
Wi = Nt.
3.2.2 Stratified Randomized Experiments
The next two experimental designs, stratification and pairing, are intended to improve the
efficiency of the design by disallowing assignments that are likely to be uninformative about
the treatment effects of interest. In a stratified randomized experiment we first partition the
[11]
population on the basis of covariate values into G strata. Formally, if the covariate space is X,
we partition X into X1, . . . ,XG, so that ∪gXg = X, and Xj ∩ Xg′ = ∅ if g 6= g′. Let Gig be an
indicator for unit i belonging to stratum g, so that Gig = 1Xi∈Xg . Let Ng be the number of units
in stratum g. Then we fix the number of treated units in each stratum as Nt,g, so that the total
number of treated units is Nt =
∑G
g=1Nt,g. The assignment probability is then
p(W |Y (0),Y (1),X) =
G∏
g=1
(
Nj
Nt,g
)−1
, for all W such that ∀g
N∑
i=1
Gij ·Wi = Nt,g.
This design rules out some assignments that are allowed in a completely randomized design, with
the hope that the assignment vectors that are disallowed are relatively uninformative compared
to assignment vectors that are allowed, for example where all men are in the treatment group
and all women in the control group.
3.2.3 Paired Randomized Experiments
In a paired randomized experiment we pair units together and randomize within the pairs. We
can think of this as an extreme case of stratification where each stratum contains exactly one
treated unit and exactly one control unit. In that case there are G = N/2 strata, and Ng = 2
and Nt,g = 1 for all g. Then
p(W |Y (0),Y (1),X) =
(
1
2
)N/2
for all W such that ∀g,
N∑
i=1
Gig ·Wi = 1.
3.2.4 Clustered Randomized Experiments
The last design we discuss is not intended to be more informative than a completely randomized
experiment with the same sample size. Rather it is a design that attemps to avoid complications
with local interactions at the unit level, as well as disallow assignments that are may be relatively
expensive in terms of data collection, and thus indirectly may attempt to increase the sample
size to improve precision. In a clustered randomized experiment, as in a stratified randomized
experiments, we start with a partitioning of the covariate space. Now, however, instead of
assigning treatments randomly to units within a cluster (the same as the stratum in the stratified
randomized experiment), treatments are assigned randomly to entire clusters, with all units
within a cluster receiving the same level of the treatment.
[12]
This design may be motivated by concerns that there are interactions between units. For
example, for educational programs it may be that exposing some children in a classroom to an
intervention has spillover effects on children in the same classroom who were not exposed to the
intervention. For that reason is may make sense to expose all children in a classroom or school
to the same treatment. Alternatively, it may be expensive to randomize at the individual level
compared to randomizing at the classroom or geographic unit level.
Again, let Gig denote the indicator for unit i belonging to cluster g, with G the total number
of clusters. Although we may vary the probability of a cluster being assigned to the treatment
group, here we focus on the simplest case where Gt out of the G clusters are selected randomly to
be assigned to the treatment group. Thus, at the cluster level we have a completely randomized
experiment. Let W g =
∑
i:Gig=1
Wi/Ng be the average value of Wi for units in cluster g, so that
the clustering implies that W g ∈ {0, 1}. More generally, one may vary the probability of being
assigned to the treatment by cluster, without requiring that all units in the same cluster having
the same treatment, although we do not consider that case here. Then:
p(W |Y (0),Y (1),X) =
(
G
Gt
)−1
,
for all W such that if Gig = Gi′g = 1, then Wi = Wi′, and
∑G
g=1W g = Gt.
4 The Analysis of Completely Randomized Experiments
In this section we discuss the analysis of the simplest form of randomized experiments, com-
pletely randomized experiments. In this setting we have a sample of N units, Nt of whom are
selected at random to receive the active treatment, and the remaining Nc = N − Nt of whom
receive the control treatment. We consider four sets of analyses. First, we study the calculation
of exact p-values for sharp hypotheses, based on the work by Fisher (1925, 1935). Second, we
consider estimation of and inference for average treatment effects, following the original work by
Neyman (1928, 1935, 1990). Third, we study the relation between the Neyman approach and
linear regression, showing how randomization justifies conventional regression analyses. Fourth,
we look at quantile treatment effects. Central to our discussion is the view of the potential out-
comes as fixed, leading to a focus on inference based on the randomization distribution, keeping
fixed the total number of units assigned to treatment and control. We will sometimes view the
[13]
sample as identical to the population of interest, and sometimes as a random sample from an
infinitely sized population of interest.
Initially we focus on the case without pretreatment variables. In Section 4.4 we allow for
the presence of covariates but maintain the focus on global targets such as the average effect
of the treatment. In Section 10 we explore the benefits of observing covariates that are not
affected by the treatment, also known as pre-treatment variables. We will illustrate some of
the discussions with analyses of an experimental evaluation of a labor market program, first
analyzed by Lalonde (1986). The data set contains information on 445 individuals, 185 in the
treatment group, and 260 in the control group. The outcome is post training earnings, and
pre-treatment variables include lagged earnings and individual characteristics.
4.1 Exact P-values for Sharp Null Hypotheses
The first analysis is based on Fisher’s (1925, 1935) work on exact p-values for sharp null hy-
potheses. See for recent discussions Rosenbaum (1992), Gail, Tian and Piantadosi (1988), and
Imbens and Rubin (2015), and in economics Young (2016). Fisher was interested in testing
sharp null hypotheses, that is, null hypotheses under which we can infer all the missing po-
tential outcomes from the observed ones. The leading null hypothesis in this class is the null
hypothesis that the treatment has no effect whatsoever:
H0 : Yi(0) = Yi(1) ∀ i = 1, . . . , N. (4.1)
The implicit alternative hypothesis is that there is at least one unit i such that Yi(0) 6= Yi(1).
Other sharp null hypothesis correspond to known constant treatment effects, but in many cases
these are less interesting and natural. However, in some cases one can use the exact p-values
in settings without sharp null hypotheses by redefining the experiment, as shown by Athey,
Eckles and Imbens (2015) in the context of network experiments (see Section 11.3 for further
discussion).
Given the sharp null hypothesis, we can infer all the missing potential outcomes. As a result
we can infer, for any statistic that is a function of Y obs, W , and X, the exact distribution of
that statistic under the null hypothesis. So, suppose we choose as our statistic the difference in
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means by treatment status:
T ave(W ,Y obs,X) = Y
obs
t − Y obsc =
1
Nt
∑
i:Wi=1
Y obsi −
1
Nc
∑
i:Wi=0
Y obsi . (4.2)
We can calculate the probability, over the randomization distribution, of the statistic taking on
a value as large, in absolute value, as the actual value given the actual treatment assigned. This
calculation gives us the p-value for this particular null hypothesis:
p = pr
(|T ave(W ,Y obs,X)| ≥ |T ave(W obs,Y obs,X)|) . (4.3)
Let us illustrate this using data from National Supported Work program, previously analyzed
by Lalonde (1986), Dehejia and Wahba (1999) and many others. The simple difference in average
post treatment earnings between treated and control is 1.79 (in thousands of dollars). To
calculate the p-value associated with this difference of 1.79, we re-assign the treatment, keeping
the number of treated and control units fixed at 185 and 240 respectively. Given the reassigned
treatment we calculate what the value of the statistic would have been. Although the observed
outcomes do not change for any unit under the null hypothesis, the value of the statistic changes
because who is in the treatment group and who is in the control group changes. Repeating this
many times we calculate the fraction of reassignment vectors that leads to a statistic that is
at least as large as 1.79 in absolute value. The p-value associated with this statistic is 0.0044,
suggesting we should clearly reject the null hypothesis that the program had no effect on earnings
whatsoever.
The main choice to be made in this procedure is the choice of statistic. A natural statistic
is the one we choose in the illustration, the difference in means by treatment status. Another
attractive choice is the difference in means of the ranks by treatment status. Here the outcomes
are first converted to ranks, normalized to have zero mean:
Ri = R(i; Y
obs
1 , . . . , Y
obs
N ) =
N∑
j=1
1Y obsj <Y obsi +
1
2
(
1 +
N∑
j=1
1Y obsj =Y obsi
)
− N + 1
2
.
The term in the middle deals with the presence of ties in the data. For the Lalonde data this
statistic leads to a p-value of 0.01. In this application the robustness to outliers does not actually
buy very much, and the presence of many zeros has a bigger impact on the difference between
the mean and rank statistics.
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This transformation improves the power of the tests in settings with outliers and thick-
tailed distributions. It is less arbitrary than, for example, simply transforming the outcome
by taking logarithms, especially in settings where such transformations are not feasible, e.g., in
settings with thicktailed distribution and a mass point at zero. There are some settings where
the transformation to ranks does not work well. An example would be a case with a large
proportion of zeros, and a very thick-tailed distribution for the outcomes for units with non-zero
outcomes.
In some cases the researcher has multiple outcomes. One can calculate exact p-values for each
of the outcomes, but obviously the probability that at least one of the p-values is less than 0.05
even if the treatment has no effect on any of the outcomes is generally larger than 0.05. There
are two modifications one can implement to address this. The simplest is to modify the test
statistic to take account of all the outcomes. For example, one could use an F-statistic, that is, a
quadratic form in the difference in average outcomes by treatment status, with the inverse of the
covariance matrix in the middle. For that statistic one can calculate the exact p-value under the
null hypothesis that there is no effect of the treatment whatsoever using the Fisher randomization
distribution. See for example Young (2016). Alternatively one can use adjustments to the p-
values to take account of the multiple testing. Traditionally such adjustments are based on
Bonferroni bounds. However, there are tighter bounds available, although they tend to be more
conservative than the exact Fisher p-values. See Romano, Shaikh and Wolf (2010) for a review
of this literature.
Rosenbaum (1992) discusses estimators for treatment effects based on rank statistics, as
opposed to simply doing tests, following Hodges and Lehmann (1970) and Doksum (1974).
Specifically he looks for values for the common treatment effect that set the rank correlation
between the residuals and the treatment equal to zero, leading to confidence intervals based on
inverting test statistics.
4.2 Randomization Inference for Average Treatment Effects
In this section we continue the analysis of completely randomized experiments, taking as fixed
the potential outcomes in the population. Here we follow the line of research that originates
in the work by Neyman (1929, 1935, 1990). Neyman was interested in estimating the average
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effect of the treatment for the sample at hand,
τ =
1
N
N∑
i=1
(
Yi(1)− Yi(0)
)
= Y (1)− Y (0). (4.4)
In addition Neyman was interested in constructing confidence intervals for such average effects.
Initially we focus purely on the finite sample, with no assumptions on any sampling that may
have led to the particular sample at hand.
As an estimator Neyman proposed the difference in average outcomes by treatment status:
τˆ = Y
obs
t − Y
obs
c , where Y
obs
t =
1
Nt
∑
i:Wi=1
Y obsi , and Y
obs
c =
1
Nc
∑
i:Wi=0
Y obsi . (4.5)
Defining
Di =Wi − Nt
N
=
{
Nc
N
if Wi = 1
−Nt
N
if Wi = 0,
so that E[Di] = 0, we can write this estimator as:
τˆ = τ +
1
N
N∑
i=1
Di ·
(
N
Nt
· Yi(1) + N
Nc
· Yi(0)
)
. (4.6)
Because all potential outcomes are fixed, the only stochastic components are the Di, and with
E[Di] = 0, the second term has expectation zero, which immediately implies that this estimator
is unbiased for the average treatment effect, τ . A more tedious calculation (e.g., Imbens and
Rubin, 2015), shows that the sampling variance of τˆ , over the randomization distribution, is:
V (τˆ ) =
S2c
Nc
+
S2t
Nt
− S
2
tc
N
, (4.7)
where S2c and S
2
t are the variances of Yi(0) and Yi(1) in the sample, defined as:
S2c =
1
N − 1
N∑
i=1
(
Yi(0)− Y (0)
)2
, and S2t =
1
N − 1
N∑
i=1
(
Yi(1)− Y (1)
)2
,
and S2tc is the sample variance of the unit-level treatment effects, defined as:
S2tc =
1
N − 1
N∑
i=1
(
Yi(1)− Yi(0)− (Y (1)− Y (0))
)2
.
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We can estimate the first two terms as
s2c =
1
Nc − 1
∑
i:Wi=0
(
Yi(0)− Y obsc
)2
=
1
Nc − 1
∑
i:Wi=0
(
Y obsi − Y obsc
)2
,
and
s2t =
1
Nt − 1
∑
i:Wi=1
(
Yi(1)− Y obst
)2
=
1
Nt − 1
∑
i:Wi=1
(
Y obsi − Y
obs
t
)2
.
These estimators are unbiased for the corresponding terms in the variance of τˆ . The third
term, S2tc (the population variance of the unit-level treatment effects Yi(1)− Yi(0)) is generally
impossible to estimate consistently because we never observe both Yi(1) and Yi(0) for the same
unit. We therefore have no direct observations on the variation in the treatment effects across
the population and cannot directly estimate S2tc.
In practice researchers therefore use the estimator for V (τˆ ) based on estimating the first two
terms by s2c and s
2
t , and ignoring the third term,
Vˆneyman =
s2c
Nc
+
s2t
Nt
. (4.8)
This leads in general to an upwardly biased estimator for V (τˆ ), and thus to conservative confi-
dence intervals. There are two important cases where the bias vanishes. First, if the treatment
effect is constant the third term is zero, and so ignoring it is immaterial. Second, if we view the
sample at hand as a random sample from an infinite population, then V (τˆ ) is unbiased for the
variance of τˆ viewed as an estimator of the population average treatment effect E[Yi(1)−Yi(0)],
rather than as an estimator of the sample average treatment effect
∑N
i=1(Yi(1)− Yi(0))/N (See
Imbens and Rubin, 2015).
To construct confidence intervals we do need to make large sample approximations. One
way to do this is to assume that the sample can be viewed as a random sample from a large
population and use a standard central limit theorem for independent and identically distributed
random variables. An alternative is to make assumptions on the properties of the sequence of
(Yi(0), Yi(1)) so that one can use a Lindenberg-type central limit theorem for independent, but
not identically distributed, random variables for the second term in (4.6). The main condition is
that the sequence of averages of the squares of Yi(0)+ Yi(1) does not diverge. The large sample
approximations do play a very different role though than in standard discussions with random
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sampling. Most importantly the estimand is defined in terms of the finite sample, not in terms
of the infinite superpopulation.
For the Lalonde data the estimate and Neyman standard error, which are up to a degrees-
of-freedom adjustment equal to the White robust standard errors (White, 1980), are
τˆ = 1.794 (ŝe 0.671).
The p-value based on the normal approximation to the distribution of the t-statistic is 0.0076,
compared to an exact p-value of 0.0044 based on the Fisher approach.
4.3 Quantile Treatment Effects
Much of the theoretical as well as the empirical literature on treatment effects has focused on
average causal effects. However, there are other causal effects that might be of interest. Of
particular interest are quantile treatment effects. These can be used as a systematic way to
uncover treatment effects that may be concentrated in tails of the distribution of outcomes, or
to estimate more robustly constant treatment effects in settings with thick-tailed distributions.
For this case there are no finite sample results in the spirit of Neyman’s results for the average
treatment effect, so we focus on the case where the sample can be viewed as a random sample
from an infinite population.
In general, let qY (s) denote the s-th quantile of the distribution of the random variable Y .
Formally,
qY (s) = inf
y
1FY (y)≥s.
Now define the s-th quantile treatment effect as the difference in quantiles between the Yi(1)
and Yi(0) distributions:
τs = qY (1)(s)− qY (0)(s). (4.9)
Such quantile treatment effects have been studied in Doksum (1974) and Lehman (1974), and
more recently in Abadie, Angrist and Imbens (2002), Chernozhukov and Hansen (2005), Firpo
(2007), Bitler, Gelbach and Hoynes (2002).
Note that τs is a difference in quantiles, and in general it is different from the quantile of the
differences, that is, the corresponding quantile of the unit-level treatment effects, qY (1)−Y (0)(s).
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Specifically, although the mean of the difference of Yi(0) and Yi(0) is equal to the difference in
the means of Yi(1) and Yi(0), in general the median of the difference Yi(1)− Yi(0) is not equal
to the difference in the medians of Yi(1) and Yi(0). There are three important issues concerning
the quantile of the treatment effects in relation to the differences in quantiles. First, the two
estimands, qY (1)(s) − qY (0)(s) and qY (1)−Y (0)(s), are equal if there is perfect rank correlation
between the two potential outcomes. In that case,
Yi(1) = F
−1
Y (1)(FY (0)(Yi(0))).
A special case of this is that where the treatment effect is additive and constant. This assumption
is implausible in many settings. However, in general it has no testable implications.
The second, related, issue is that in general the quantile of the unit-level treatment effects,
qY (1)−Y (0)(s), is not identified. Even with large scale experiments we can only infer the two
marginal distributions of Yi(0) and Yi(1). Nothing about the joint distribution that cannot be
expressed in terms of these two marginal distributions can be inferred from the data.
A third issue is the question which of the two quantile treatment effects, the difference
in quantiles, qY (1)(s) − qY (0)(s), or the quantile of the difference, qY (1)−Y (0)(s), is the more
interesting object for policy makers. To discuss that question it is useful to think about the
possible decisions faced by a policy maker. If a policy maker is commited to making one of the
two treatments universal and is deciding between exposing all units to the control treatment or
to the active treatment, the answer should depend only on the two marginal distributions, and
not on aspects of the joint distribution that cannot be expressed in terms of the two marginal
distributions. This suggests that the difference in quantiles may be a more natural object to
consider, although there are some cases, such as legal settings, where unit-level treatment effects
are of primary interest.
For these reasons we focus on the difference in quantiles, τs. Inspecting this estimand for
different values of s may reveal that a particular treatment affects the lower or upper tail
more than the center of the distribution. In addition, in cases where the average effects of the
treatment may be imprecisely estimated because of thick-tailed distributions, quantile treatment
effect estimates may be very informative.
Here we estimate quantile effects for the Lalonde data for the quantiles 0.10, 0.25, 0.50, and
0.75. For each quantile we estimate the average effect and calculate standard errors using the
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bootstrap. We also use the difference in quantiles as a statistic in an exact p-value calculation.
The results for the exact tests are quite different from those based on estimating the effects and
Table 1: Estimates of Quantile Treatment Effects for Lalonde Data.
quantile est bootstrap s.e. exact p-value
0.10 0.00 (0.00) 1.000
0.25 0.49 (0.35) 0.003
0.50 1.04 (0.90) 0.189
0.75 2.34 (0.91) 0.029
0.90 2.78 (1.97) 0.071
calculating standard errors. The reason is that the quantile estimates are far from normally
distributed. Mainly because of the 30% zeros in the outcome distribution the distribution of the
difference in the lower quantiles has a substantial point mass at zero. Because of the substantial
proportion of individuals with zero earnings, the bootstrap standard error for the 0.10 quantile
is essentially zero.
4.4 Covariates in Completely Randomized Experiments
In this section we discuss some additional analyses that a researcher may wish to carry out if
covariates are recorded for each unit. Later we discuss regression methods, but here we discuss
some general principles. We focus here on the case where the randomization took place without
taking into account the covariates. In fact, as we discuss in Section 3.2.2, if one has covariates
observed prior to the randomization, one should modify the design of the experiment and carry
out a stratified randomized experiment rather than as a completely randomized experiment. If
one has a well-conducted randomized experiment where the randomization did not take into
account the covariates, one does not need regressors in order to estimate average treatment
effects. The simple difference in means by treatment status, τˆ = Y
obs
t − Y
obs
c is unbiased for the
average effect. So, the question is what the role is of covariates. There are two principal roles.
First, incorporating covariates may make analyses more informative. For example, one can
construct test statistics in the Fisher exact p-value approach that may have more power than
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statistics that do not depend on the covariates. Similary, by estimating average treatment effects
within subpopulations, and then averaging up the estimates appropriately, the results will be
more precise if the covariates are sufficiently strongly correlated with the potential outcomes.
There is potentially a small-sample cost to ex post adjustment. For example, if the covariates
are independent of the potential outcomes, this ex post adjustment will lower precision slightly.
In practice the gains in precision tend to be modest.
Second, if the randomization was compromised, adjusting for covariate differences may re-
move biases. Even if the original randomization was done appropriately, this may be relevant if
there are missing data and the analysis uses only complete cases where there is no guarantee of
ex ante comparability between treated and control units.
To illustrate this, let us consider the Lalonde data, and focus on the indicator that the lagged
earnings are positive as a covariate. The overall estimate of the average treatment effect is
τˆ = 1.79 (ŝe = 0.67).
For the individuals with positive prior earnings the effect is
τˆp = 1.69 (ŝep = 1.31).
For the individuals with zero prior earnings the effect is
τˆz = 1.71 (ŝez = 0.74).
Combining the two estimates leads to
τˆ = pˆ · τˆp + (1− pˆ) · τˆz = 1.70 (ŝe = 0.66),
with a standard error that is barely smaller than that without adjusting for positive prior
earnings, 0.67.
The two arguments regarding the role of covariates in the analysis of randomized experiments
also raise the question whether there is any reason to compare the covariate distributions by
treatment status as part of the analysis. There are a couple of reasons why such a comparison
may be useful. If there is some distance between the agencies carrying out the original ran-
domization and the researcher analyzing the data it may be useful as check on the validity of
the randomization to assess whether there are any differences in covariates. Second, even the
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randomization was carried out appropriately, it may be informative to see whether any of the
key covariates were by chance relatively imbalanced between treatment and control group, so
that prior to seeing the outcome data an analysis can be designed that addresses these presum-
ably modest imbalances. Third, if there is reason to believe that the sample to be analyzed
is not identical to the population that was randomized, possibly because of attrition, or item
non-response with incomplete observations dropped from the analysis, it is useful to assess how
big the imbalances are that resulted from the sample selection. Tabel 2 presents the differences
in covariates for the experimental Lalonde data.
Table 2: Covariates in Lalonde Data
Average
Covariate Treated Controls Difference s.e. exact p-value
African-American 0.84 0.83 0.02 (0.04) 0.700
Hispanic 0.06 0.11 -0.05 (0.03) 0.089
age 25.8 25.0 0.8 (0.7) 0.268
education 10.3 10.1 0.3 (0.2) 0.139
married 0.19 0.15 0.045 (0.04) 0.368
no-degree 0.71 0.84 -0.13 (0.04) 0.002
earnings 1974 2.10 2.11 -0.01 (0.50) 0.983
unemployed 1974 0.71 0.75 -0.04 (0.04) 0.329
earnings 1974 1.53 1.27 0.27 (0.31) 0.387
unemployed 1975 0.60 0.69 -0.09 (0.05) 0.069
We see that despite the randomization there is substantial evidence that the proportion of
individuals with a degree in the treatment group is lower than in in the control group. This
conclusion survives adjusting for the multiplicity of testing.
5 Randomization Inference and Regression Estimators
In this section we discuss regression and more generally modelling approaches to estimation and
inference in the context of completely randomized experiments. Although these methods re-
main the most popular way of analyzing data from randomized experiments, we suggest caution
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in using them. Some of these comments echo the concerns raised by others. For example, in
the abstract of Freedman (2008), he writes “Regression adjustments are often made to exper-
imental data. Since randomization does not justify the models, almost anything can happen”
(Freedman, 2008, abstract) and similar comments are made by Deaton (2010) Young (2016),
and Imbens and Rubin (2015). Regression methods were not originally developed for analyzing
data from randomized experiments, and the attempts to fit the appropriate analyses into the
regression framework requires some subtleties. In particular there is a disconnect between the
way the conventional assumptions in regression analyses are formulated and the implications
of randomization. As a result it is easy for the researcher using regression methods to go be-
yond analyses that are justified by randomization, and end up with analyses that rely on a
difficult-to-assess mix of randomization assumptions, modelling assumptions, and large sample
approximations. This is particularly true once one uses nonlinear methods. See for additional
discussions Lesaffre and Senn (2003), Samii and Aronow (2012), Rosenbaum (2002), Lin (2013),
Schochet (2010), Young (2016), Senn (1994).
Ultimately we recommend that researchers wishing to use regression or other model-based
methods rather than the randomization-based methods we prefer, do so with care. For example,
using only indicator variables based on partitioning the covariate space, rather than using multi-
valued variables as covariates in the regression function preserves many of the finite sample
properties that simple comparisons of means have, and leads to regression estimates with clear
interpretations. In addition, in many cases the potential gains from regression adjustment can
also be captured by careful ex ante design, that is, through stratified randomized experiments to
be discussed in the next section, without the potential costs associated with ex post regression
adjustment.
5.1 Regression Estimators for Average Treatment Effects
In ordinary least squares, one regresses the observed outcome Y obsi on the indicator for the
treatment, Wi, and a constant:
Y obsi = α + τ ·Wi + εi, (5.1)
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where εi is an unobserved error term. The least squares estimator for τ is based on minimizing
the sum of squared residuals over α and τ ,
(τˆols, αˆols) = argmin
τ,α
N∑
i=1
(Y obsi − α− τ ·Wi)2,
with solution
τˆols =
∑N
i=1(Wi −W ) · (Y obsi − Y
obs
)∑N
i=1(Wi −W )2
= Y
obs
t − Y obsc , and αˆols = Y obs − τˆols ·W.
The least squares estimate of τ is identical to the simple difference in means, so by the Neyman
results discussed in Section 4.2, the least squares estimator is unbiased for the average causal
effect. However, the assumptions that are typically used to justify linear regression are sub-
stantially different from the randomization that justifies Neyman’s analysis. In addition, the
unbiasedness claim in the Neyman analysis is conceptually different from the one in conven-
tional regression analysis: in the first case the repeated sampling paradigm keeps the potential
outcomes fixed and varies the assignments, whereas in the latter the realized outcomes and as-
signments are fixed but different units with different residuals, but the same treatment status,
are sampled. The assumptions typically used in regression analyses are that, in the infinite popu-
lation the sample was drawn from, the error terms εi are independent of, or at least uncorrelated
with, the treatment indicator Wi. This assumption is difficult to evaluate, as the interpretation
of these residuals is rarely made explicit beyond a vague notion of capturing unobserved factors
affecting the outcomes of interest. Textbooks therefore often stress that regression estimates
measure only association between the two variables, and that causal interpretations are not in
general warranted.
It is instructive to see the formal implications of the randomization for the properties of
the least squares estimator, and to see how the randomization relates to the standard versions
of the regression assumptions. To build this connection between the two repeated sampling
paradigms it is very convenient to view the sample at hand as a random sample from an infinite
population. This allows us to think of all the variables as random variables, with moments
defined as population averages and with a distribution induced by random sampling from this
infinite population. Define
τ = E [Yi(1)− Yi(0)] , and α = E [Yi(0)] .
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Then define the residual as
εi = Yi(0)− α +Wi ·
{
Yi(1)− Yi(0)− τ
}
= (1−Wi) ·
{
Yi(0)− E[Yi(0)]
}
+Wi ·
{
Yi(1)− E[Yi(1)]
}
.
This implies we can write the regression as in (5.1). Now the error term has a clear meaning
as the difference between potential outcomes and their population expectation, rather than as
the difference between the realized outcome and its conditional expectation given the treatment.
Moroever, the independence ofWi and (Yi(0), Yi(1)), directly implied by the randomization, now
has implications for the properties of the error term. Specifically, the randomization implies that
the average residuals for treated and control units are zero:
E[εi|Wi = 0] = 0, and E[εi|Wi = 1] = 0.
Note that random assignment of the treatment does not imply that the error term is independent
of Wi. In fact, in general there will be heteroskedasticity, and we need to use the Eicker-Huber-
White robust standard errors to get valid confidence intervals.
It may appear that this is largely semantics, and that using regression methods here makes no
difference in practice. This is certainly true for estimation in this simple case without covariates,
but not necessarily for inference. The conventional least squares approach suggests using the
robust (Eicker-Huber-White) standard errors. Because the general robust variance estimator
has no natural degrees-of-freedom adjustment, these standard robust variance estimators differs
slightly from the Neyman unbiased variance estimator Vˆneyman :
Vˆrobust =
s2c
Nc
· Nc − 1
Nc
+
s2t
Nt
· Nt − 1
Nt
. (5.2)
The Eicker-Huber-White variance estimator is not unbiased, and in settings where one of the
treatment arms is rare, the difference may matter. For the Duflo-Hanna-Ryan data on the effect
of teacher presence on educational achievement (Duflo, Hanna, and Ryan, 2012), this leads to
Yˆ obsi = 0.5805 + 0.2154×Wi,
(0.0256) (0.0308)
[0.0311]
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with the Eicker-Huber-White standard errors in parentheses and the Neyman standard error
in brackets. Because both subsample sizes are large enough (Nc = 54 and Nt = 53), there is
essentially no difference in the standard errors. However, if we modify the sample so that there
are Nc = 54 control units but only Nt = 4 treated units, the standard errors are quite different,
0.1215 for the Eicker-Huber-White standard errors, and 0.1400 for the Neyman standard errors.
Although there are refinements of the general Eicker-Huber-White variance estimator, there
are none that are unbiased in general. The difference with the Neyman variance estimator relies
on the fact that the only regressor in the Neyman variance estimator is a binary indicator. More-
over, the Neyman variance estimator, fitting into the classic Behrens-Fisher problem, suggests
using a t-distribution rather than a normal distribution with the degrees of freedom dependent
on the size of the two treatment groups. See Imbens and Kolesar (2015) and Young (2016)
for recent discussions with illustrations how the distribution of the covariates matters for the
standard errors.
5.2 Regression Estimators with Additional Covariates
Now let us turn to the case with additional covariates beyond the treatment indicator Wi, with
these additional covariates denoted by Xi. These additional covariates are not affected by the
treatment by definition, that is, they are pre-treatment variables. Moreover, we assume here
that these covariates did not affect the assignment, which we continue to assume is completely
random. It is the presence of these covariates that often motivates using regression methods
rather than simple differences by treatment status. There are generally three motivations for
including these covariates into the analysis. First, they may improve the precision of the esti-
mates. Second, they allow for estimation of average effects for subpopulations and in general
for assessments of heterogeneity in treatment effects. Third, they may serve to remove biases in
simple comparisons of means if the randomization was not adequate. These are somewhat dis-
tinct, although related, goals, however, and regression methods are not necessarily the optimal
choice for any of them. In general, again, we wish to caution against the routine way in which
regression methods are often applied here.
There are two ways covariates are typically incorporated into the estimation strategy. First,
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they can be included additively through the regression model
Y obsi = α + τ ·Wi + β ′X˙i + εi. (5.3)
Here X˙i = Xi − X is the covariate measured in deviations from its mean. Using deviations
from means does not affect the point estimates of τ or β, only that of the intercept α, but this
transformation of the covariates is convenient once we allow for interactions. Estimating this
regression function for the Duflo-Hanna-Ryan data changes the point estimate of the average
effect to 0.1921 and leaves the standard error unchanged at 0.0298. The R-squared in the original
regression was 0.3362, and the two additional covariates increase this to 0.3596, which is not
enough to make a difference in the standard error.
Second, we can allow for a model with a full set of interactions:
Y obsi = α + τ ·Wi + β ′X˙i + γ′X˙i ·Wi + εi. (5.4)
In general the least squares estimates based on these regression functions are not unbiased for
the average treatment effects over the randomization distribution given the finite population.
There is one exception. If the covariates are all indicators and they partition the population,
and we estimate the model with a full set of interactions, Equation (5.4), then the least squares
estimate of τ is unbiased for the average treatment effect. To see this, consider the simplest
case with a single binary covariate. In that case we can think of average treatment effects τx for
each value of x. We can also think of τˆx estimated separately on the corresponding part of the
subpopulation. If X is the average value of Xi in the sample, then
τˆ = τˆ1 ·X + τˆ0 · (1−X), and γˆ = τˆ1 − τˆ0.
Below in Section 10.3.1, we discuss machine learning methods for partitioning the covariate
space according to treatment effect heterogeneity; if we construct indicators for the element
of the partition derived according to an “honest causal tree” (Athey and Imbens, 2016) and
incorporate them into (5.4), then the resulting average treatment effect (estimated on what
Athey and Imbens (2016) refer to as the estimation sample) is unbiased over the randomization
distribution. This result extends conceptually to the case where all regressors are indicators. In
that case all least squares estimates are weighted averages of the within-cell estimated average
effects.
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If we are willing to make large sample approximations, we can also say something about the
case with multivalued covariates. In that case, τˆ is (asymptotically) unbiased for the average
treatment effect. Moreoever, and this goes back to the first motivation for including covariates,
the asymptotic variance for τˆ is less than that of the simple difference estimator by a factor equal
to 1−R2 from including the covariates relative to not including the covariates. It is important
that these two results do not rely on the regression model being true in the sense that the
conditional expectation of Y obsi is actually linear in the covariates and the treatment indicator
in the population. Because of the randomization there is zero correlation in the population
between Wi and the covariates Xi, which is sufficient for the lack of bias from including or
excluding the covariates. However, the large sample approximation needs to be taken seriously
here. If in fact the covariates have very skewed distributions, the finite sample bias in the linear
regression estimates may be substantial, as Freedman (2008) points out. At the same time, the
gain in precision is often modest as the covariates often only have limited explanatory power.
The presence of non-zero values for γ imply treatment effect heterogeneity. However, the
interpretation of the γ depends on the actual function form of the conditional expectations. Only
if the covariates partition the population do these γ have a clear interpretation as differences
in average treatment effects. For that reason it may be easier to convert the covariates into
indicator variables. It is unlikely that the goodness of fit of the regression model is much affected
by such transformations, and both the interpretation and the finite sample unbiasedness would
be improved by following that approach.
For the Duflo-Hanna-Ryan (2012) data,
Yˆ obsi =0.59+ 0.192×Wi+ 0.001×X1i− 0.004×X2i− 0.006×X1i ×Wi
(0.02) (0.03) (0.002) (0.01) (0.003)
+0.017 ×X2i ×Wi
(0.01)
The inclusion of the two covariates with the full set of interactions does not affect the point
estimate of the average treatment effect, nor its standard error.
Alternatively, if we run the regression with an indicator for X1i > 37 (teacher score greater
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than the median), we get
Yˆ obsi =0.60+ 0.188×Wi+ 0.10× 1{X1i>37} −0.06× 1{X1i>37} ×Wi
(0.02) (0.03) (0.05) (0.06)
Now the coefficient on the interaction is directly interpretable as an estimate of the difference in
the average effect for teachers with a score higher than 37 versus teachers with a score less than
or equal to 37. Ultimately there is very little gain in precision in the estimator for the average
treatment effect.
6 The Analysis of Stratified and Paired Randomized Ex-
periments
In this section we discuss the analyses for two generalizations of completely randomized exper-
iments. First, consider stratified randomized experiments. In that case the covariate space is
partitioned into a finite set. Within each of these subsets a completely randomized experiment
is carried out. In the extreme case where the partition is such that within each subset there
are exactly two units, and the designs corresponds to randomly assigning exactly one of these
two units to the treatment and the other to the control group we have a paired randomized
experiment. Both these designs can be thought of as attempting to capture the gains from
adjusting from observable differences between units by design, rather than by analysis as in the
previous section. As such they capture the gains from ex post regression adjustment without
the potential costs of linear regression, and therefore stratification is generally preferable over
regression adjustment. In the current section we discuss the analyses of such experiments, and
in Section 7.2 the design aspects.
6.1 Stratified Randomized Experiments: Analysis
In a stratified randomized experiment the covariate space is partitioned into a finite set of
subsets. Within each of these subsets a completely randomized experiment is carried out, after
which the results are combined. If we analyze the experiment using Neyman’s repeated sampling
approach the analysis of stratified randomized experiments is straightforward. Suppose there
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are G strata within which we carry out a completely randomized experiment, possibly with
varying treatment probabilities. Let τg be the average causal effect of the treatment for all units
within stratum g. Within this stratum we can estimate the average effect as the difference in
average outcomes for treated and control units:
τˆg = Y
obs
t,g − Y obsc,g ,
and we can estimate the within-stratum variance, using the Neyman results, as
Vˆ(τˆg) =
s2t,g
Nt,g
+
s2c,j
Nc,g
,
where the j-subscript indexes the stratum. We can then estimate the overall average effect of
the treatment by simply averaging the within-stratum estimates weighted by the stratum share
Ng/N :
τˆ =
G∑
g=1
τˆg · Ng
N
, with estimated variance Vˆstrat(τˆ) =
G∑
g=1
Vˆ(τˆg) ·
(
Ng
N
)2
.
There is a special case that is of particular interest. Suppose the proportion of treated units
is the same in all strata. In that case the estimator for the average treatment effect is equal to
the difference in means by treatment status,
τˆ =
G∑
g=1
τˆg · Ng
N
= Y
obs
t − Y
obs
c ,
which is the estimator we used for the completely randomized experiment. In general, however,
the variance based on the completely randomized experiment set up,
Vˆneyman =
s2t
Nt
+
s2c
Nc
,
will be conservative compared to the variance that takes into account the stratification, Vˆstrat(τˆ):
the latter takes into account the precision gain from stratification.
6.2 Paired Randomized Experiments: Analysis
Now let us consider a paired randomized experiment. Starting with N units in our sample,
N/2 pairs are constructed based on covariate values so that within the pairs the units are more
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similar in terms of covariate values. Then, within each pair a single unit is chosen at random
to receive the active treatment and the other unit is assigned to the control group. The average
treament effect within the pair is estimated as the difference in outcome for the treated unit
and the control unit:
τˆg =
∑
i:Gig=1,Wi=1
Y obsi −
∑
i:Gig=1,Wi=0
Y obsi .
The overall average effect is estimated as the average over the within-pair estimates:
τˆ =
1
N/2
N/2∑
g=1
τˆg = Y
obs
t − Y obsc .
So far this is similar to the analysis of a general stratified experiment, and conceptually the two
designs are closely related.
The complications arise when estimating the variance of this estimator, as an estimator of
the average effect over the strata, τ =
∑N/2
g=1 τg · 2/N . In the stratified randomized experiment
case we estimated the variance in two steps, first estimating the within-stratum variance for
stratum g as
Vˆ(τˆg) =
s2t,g
Nt,g
+
s2c,g
Nc,g
,
followed by averaging this over the strata. However, this variance estimator requires at least
two treated and at least two control units in each stratum, and thus is not feasible in the paired
randomized experiment case with only one treated and one control unit in each stratum or pair.
Instead typically the following variance estimator is used:
Vˆ(τˆ) =
1
N/2 · (N/2− 1)
N/2∑
g=1
(τˆg − τˆ)2 , (6.1)
the variance of the τˆg over the pairs. This variance estimator is conservative if viewed as an
estimator of τ =
∑N/2
g=1 τg · 2/N . However, suppose we view the pairs as being randomly drawn
from a large super-population, with population average treatment effect equal to τ ∗ = E[τg].
Then the variance of τˆ , viewed as an estimator of τ ∗, can be estimated using Vˆ(τˆ ).
Because in this case the proportion of treated units is the same in each pair, namely 1/2,
we can also use the variance based on analysing this as a completely randomized experiment,
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leading to:
Vˆneyman =
s2t
Nt
+
s2c
Nc
. (6.2)
In general this will be conservative, and more so than necessary.
Let us illustrate this with data from the Children’s Television Workshop experiment. See
Imbens and Rubin (2015) for details. There are eight pairs of classrooms in this experiment,
with one classroom in each pair shown the Electric Company, a children’s television program.
The outcome is a post-test score, leading to
τˆ = 13.4, (ŝepair = 4.6),
where the standard error is calculated as in Equation (6.1), taking into account the paired design.
The variance estimate based on the interpretation as a completely randomized experiment as in
Equation (6.2), rather than a paired experiment, is sˆeneyman = 7.8, almost twice the size. There
is a substantial gain from doing the paired randomized experiment in this case.
7 The Design of Randomized Experiments and the Ben-
efits of Stratification
In this section we discuss some issue related to the design of randomized experiments. First we
discuss the basic power calculations for completely randomized experiments. Second we discuss
the benefits of stratification, and its limit, pairwise randomization, in terms of the expected
precision of the resulting experiments. Finally we discuss issues related to re-randomization if
one feels the randomization did not produce the desired balance in covariates between treatment
and control groups. Ultimately our recommendation is that one should always stratify as much
as possible, up to the point that each stratum contains at least two treated and two control
units. Although there are in principle some benefits in terms of expected precision to using
paired designs rather than stratified designs with two treated and two control units, these tend
to be small and because there are some real costs in terms of analyses we recommend the
stratified rather than paired designs. If the stratification is done appropriately, there should be
no need for re-randomization.
[33]
7.1 Power Calculations
In this section we look at some simple power calculations for randomized experiments. These
are intended to be carried out prior to any experiment, in order to assess whether the proposed
experiment has a reasonable chance of finding results of the size that one might reasonably
expect. These analyses depend on a number of inputs, and can focus on various outputs. Here
we largely focus on the formulation where the output is the minimum sample size required to
find treatment effects of a pre-specified size with a pre-specified probability. Alternatively, one
can also focus on the treatment size one would be likely to find given a particular sample size.
For details on these and similar calculations a standard reference is Cohen (1988). See also
Murphy, Myors, and Wollach, (2014).
Let us consider a simple case where for a sample of size N , we would observe values for
an outcome for the N units, Y obs1 , . . . , Y
obs
N , and a treatment indicator W1, . . . ,WN . We are
interested in testing the hypothesis that the average treatment effect is zero:
H0 : E[Yi(1)− Yi(0)] = 0,
against the alternative that the average treatment effect differs from zero:
Ha : E[Yi(1)− Yi(0)] 6= 0.
We restrict the size of the test, the probability of rejecting the null hypothesis when it is in
fact true, to be less than or equal to α. Often, following Fisher (1925), we choose α = 0.05
as the statistical significance level. In addition, we want the power of the test, the probability
of rejecting the null when it is in fact false, to be at least equal to β, in the case where the
true average treatment effect is τ = E[Yi(1) − Yi(0)] for some prespecified value of τ . Let
γ =
∑
iWi/N be the proportion of treated units. For simplicity we assume that the conditional
outcome variance in each treatment arm is the same, σ2 = V(Yi(0)) = V(Yi(1)). We look for
the minimum sample size N = Nc +Nt, as a function of α, β, τ , σ
2, and γ.
To test the null hypothesis of no average treatment effect we look at the T-statistic
T =
Y
obs
t − Y obsc√
S2Y /Nt + S
2
Y /Nc
≈ Y
obs
t − Y obsc√
σ2/Nt + σ2/Nc
.
We reject the null hypothesis of no difference if the absolute value of this t-statistic, |T |, exceeds
Φ−1 (1− α/2). Thus, if α = 0.05, the threshold would be Φ−1 (1− α/2) = 1.96. We want
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the rejection probability to be at least β, given that the alternative hypothesis is true with
the treatment effect equal to τ . In general the difference in means minus the true treatment
effect τ , scaled by the standard error of that difference, has approximately a standard normal
distribution:
Y
obs
t − Y obsc − τ√
σ2/Nt + σ2/Nc
≈ N (0, 1).
This implies that the t-statistic has an approximately normal distribution:
T ≈ N
(
τ√
σ2/Nt + σ2/Nc
, 1
)
.
Now, a simple calculation implies that the null hypothesis will be rejected with probability
pr
(|T | > Φ−1 (1− α/2)) ≈ Φ(−Φ−1 (1− α/2) + τ√
σ2/Nt + σ2/Nc
)
+Φ
(
−Φ−1 (1− α/2)− τ√
σ2/Nt + σ2/Nc
)
.
The second term is small, so we ignore it. Thus we want the probability of the first term to be
equal to β, which requires
β = Φ
(
−Φ−1 (1− α/2) + τ√
σ2/Nt + σ2/Nc
)
,
leading to
Φ−1 (β) = −Φ−1 (1− α/2) + τ
√
N
√
(γ(1− γ)
σ
.
This leads to a required sample size
N =
(Φ−1 (β) + Φ−1 (1− α/2))2
(τ 2/σ2) · γ · (1− γ) . (7.1)
For example, let us consider a setting close to the Lalonde data. The standard deviation
of the outcome is approximately 6, although that may have been difficult to assess before the
experiment. Suppose we choose γ = 0.5 (equal sample sizes for treated and controls, which
is optimal in the case with homoskedasticity, and typically close to optimal in other cases),
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α = 0.05 (test at 0.05 level). Suppose also that we are looking to be able to find an effect of
1 (thousand dollars), which is a substantial amount given the average pre-program earnings of
these individuals, and that we choose β = 0.8 (power of 0.8). Then
N =
(Φ−1 (β) + Φ−1 (1− α/2))2
(τ 2/σ2Y ) · γ · (1− γ)
=
(Φ−1 (0.8) + Φ−1 (0.975))
2
0.1672 · 0.52 = 1, 302,
so that the minimum sample size is 1,302, with 651 treated and 651 controls. If the effect we
wish to have power of 0.8 for is 2, then the required sample size would be substantially smaller,
namely 282, split equally between 142 treated and 142 controls.
7.2 Stratified Randomized Experiments: Benefits
In this section we discuss the benefits of stratification in randomized experiments. Mostly this
discussion is based on the special case where the ratio of the number of treated units to the
total number of units is the same in each stratum. In this case the intended benefit of the
stratification is to achieve balance in the covariates underlying the stratification. Suppose there
are only two strata, containing, respectively, women and men. If the total sample size is 100,
with 50 women and 50 men, and there are 60 individuals to be assigned to the treatment group
and 40 to the control group, stratification would ensure that in the treatment group there are 30
women and 30 men, and the 20 of each sex in the control group. This would avoid a situation
where, by chance, there were 25 women and 35 men in the treatment group, and 25 women and
15 men in the control group. If the outcomes were substantially correlated with the sex of the
individual, such a random imbalance in the sex ratio in the two treatment groups would reduce
the precision from the experiment. Note that without stratification the experiment would still
be valid, and, for example, still lead to exact p-values. Stratifying does not remove any bias, it
simply leads more precise inferences than complete randomization.
Although it is well known that stratification on covariates is beneficial if based on covariates
that are strongly correlated with the outcomes, there appears to be confusion in the literature
concerning the benefits of stratification in small samples if this correlation is weak. Bruhn and
McKenzie (2007) document this in a survey of researchers in development economics, but the
confusion is also apparent in the statistics literature. For example, Snedecor and Cochran (1989,
page 101) write:
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“If the criterion has no correlation with the response variable, a small loss in accuracy
results from the pairing due to the adjustment for degrees of freedom. A substantial
loss may even occur if the criterion is badly chosen so that member of a pair are
negatively correlated.”
Box, Hunter and Hunter (2005, page 93) also suggest that there is a tradeoff in terms of accuracy
or variance in the decision to stratify, writing:
“Thus you would gain from the paired design only if the reduction in variance from
pairing outweighed the effect of the decrease in the number of degrees of freedom of
the t distribution.”
This is somewhat counterintuitive: if one stratifies on a covariate that is independent of all
other variables, then stratification is obviously equivalent to complete randomization. In the
current section we argue that this intuition is correct and that in fact there is no tradeoff. We
present formal results that show that in terms of expected-squared-error, stratification (with the
same treatment probabilities in each stratum) cannot be worse than complete randomization,
even in small samples, and even with little, or even no, correlation between covariates and
outcomes. Ex ante, committing to stratification can only improve precision, not lower it. There
is two important qualifications to this result. First, ex post, given the joint distribution of the
covariates in the sample, a particular stratification may be inferior to complete randomization.
Second, the result requires that the sample can be viewed as a (stratified) random sample from
an infinitely large population, with the expectation in the expected-squared-error taken over
this population. This requirement guarantees that outcomes within strata cannot be negatively
correlated.
The lack of any finite sample cost to (ex ante) stratification in terms of expected-squared-
error contrasts with the potential cost of ex post stratification, or regression adjustment. Ex
post adjustment for covariates through regression may increase the finite sample variance, and in
fact it will strictly increase the variance for any sample size, if the covariates have no predictive
power at all.
However, there is a cost to stratifying on a variable that has no association with the potential
outcomes. Although there is no cost to stratification in terms of the variance, there is a cost
in terms of estimation of the variance. Because there are unbiased estimators for the variance,
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it follows that if the variance given stratification is less than or equal to the variance without
stratification, it must be that the expectation of the estimated variance given stratification is
less than or equal to the expectation of the estimated variance without stratification. However,
the estimator for the variance given stratification typically has itself a larger variance, related to
the degrees of freedom adjustment. In our view this should not be interpreted, however, as an
argument against stratification. One can always use the variance that ignores the stratification:
this is conservative if the stratification did in fact reduce the variance. See Lynn and McCulloch
(1992) for a similar argument in the context of paired randomized experiments.
We state the formal argument for a simplified case where we have a single binary covariate,
Xi ∈ {f,m} (females and males). we start with a large (infinitely large) superpopulation that
expectations and variances refer to. We will draw a sample of size N from this population
and then assign treatments to each unit. For simplicity we assume that N/4 is an integer.
Each unit is characterized by a triple (Yi(0), Yi(1), Xi), where Xi is a binary indicator. In the
superpopulation Xi has a binomial distribution with support {f,m} (females and males) with
pr(Xi = f) = 1/2. Let µft = E[Yi(1)|Xi = f], µfc = E[Yi(0)|Xi = f], µmt = E[Yi(1)|Xi = m], and
µmc = E[Yi(0)|Xi = m], and similarly for the variances.
We consider the following sampling scheme. We randomly sample N/2 units from each of
the two strata. Given a sample of X1, . . . , XN we consider two randomization schemes. In the
first we randomly select N/2 units out of the sample of N units to be assigned to the treatment
group. We refer to this as the completely randomized assignment, C. Second, we consider the
following stratified randomization scheme, denoted by S. For the stratified design randomly
select N/4 from each stratum to be assigned to the treatment, and assign the remainder to the
control group. In both cases we estimate the average treatment effect as
τˆ = Y
obs
t − Y obsc .
We consider the properties of this estimator over repeated randomizations, and repeated
random samples from the population. It follows trivially that under both designs, the estimator
is unbiased for the population average treatment effect under the randomization distribution.
The differences in performance between the estimators and the designs are solely the result of
differences in the variances. The exact variance for a completely randomized experiment can be
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written as
VC =
1
4 ·N ·
(
(µfc − µmc)2 + (µft − µmt)2
)
+
1
N
· (σ2ft + σ2fc)+ 1N · (σ2mt + σ2mc) .
The variance for the corresponding stratified randomized experiment is
VS =
1
N
· (σ2ft + σ2fc)+ 1N · (σ2mt + σ2mc) .
Thus, the difference in the two variances is
VC − VS = 1
4 ·N ·
(
(µfc − µmc)2 + (µft − µmt)2
) ≥ 0.
Therefore, stratification leads to variances that cannot be higher than those under a completely
randomized experiment. There can only be equality if neither of the potential outcomes is
correlated with the covariate, and µfc = µmc and µft = µmt. This is the main argument for our
recommendation that one should always stratify.
The inability to rank the conditional variance is useful in understanding the Snedecor and
Cochran quote in the introduction. If the strata are defined in terms of a continuous covariate,
than in a particular sample, it is possible that stratification leads to larger variances conditional
on the covariate values (and in the special case of paired experiments, to negative correlations
within pairs). That is not possible on average, that is, over repeated samples randomly drawn
from large strata, rather than conditional on the covariate values in a single sample. As men-
tioned before, the large strata qualification here is important: if the strata we draw from are
small, say litters of puppies, it may well be that the within-stratum correlation is negative, but
that is not possible if all the strata are large: in that case the correlation has to be non-negative.
Now let us consider two estimators for the variance. First define, for w = c, t, and x = f,m,
s2xw =
1
Nxw − 1
∑
i:Wi=1{w=t},Xi=x
(
Y obsi − Y
obs
xw
)2
and s2w =
1
Nw − 1
∑
i:Wi=1{w=t}
(
Y obsi − Y
obs
w
)2
.
The natural estimator for the variance under the completely randomized experiment is:
VˆC =
s2c
Nc
+
s2t
Nt
, with E[VˆC] = VC.
For a stratified randomized experiment the natural variance estimator, taking into account the
stratification, is:
VˆS =
Nf
Nf +Nm
·
(
s2fc
Nfc
+
s2ft
Nft
)
+
Nm
Nf +Nm
·
(
s2mc
Nmc
+
s2mt
Nmt
)
with E[VˆS] = VS.
[39]
Hence, E[VˆS] ≤ E[VˆC]. Nevertheless, in a particular sample, with values (Y ,W ,X), it may well
be the case that the realized value of the completely randomized variance estimator VˆC(Y ,W ,X)
is less than that of the stratified variance VˆS(Y ,W ,X). To be more specific, consider the case
where the stratification is not related to the potential outcomes at all. In that case the two
variances are identical in expectation, E[VˆS] = E[VˆC], but the variance of VˆS is larger than the
variance of VˆC, V(VˆS) < V(VˆC). As a result the power of a t-test based on VˆS will be slightly
lower than the power of a t-test based on VˆC. Nevertheless, in practice we recommend to always
stratify whenever possible.
7.3 Re-randomization
Suppose one is conducting a randomized experiment. For the study population the researcher
has collected some background characteristics and has decided to assign the units to the treat-
ment or control group completely at random. Although this would in general not be optimal,
it may be that the researcher decided it was not worth the effort investigating a better design,
and just went ahead with the complete randomization. Now, however, suppose that after the
random assigmnent has been decided, but prior to the actual implementation of the assignment,
the researcher compares average pretreatment values by treatment status. In expectation these
should be identical for all covariates, but obviously in reality these will differ somewhat. Now
suppose that one of the most important covariates does actually show a substantial difference
between the assigned treatment and control group. It need not be, although it may be statis-
tically significant at conventional levels even if the randomization was done properly, simply
because there is a substantial number of covariates, or simply by chance. What should one
do in that case? More specifically, should one go back to the drawing board and re-randomize
the treatment assignment so that the important covariate is better balanced? This question
of re-randomization has received some attention in the empirical development literature. One
paper that raised the question forcefully in this literature is Bruhn and McKenzie (2007). Theo-
retical paper discussing some of the formal aspects are Morgan and Rubin (2012) and Banerjee,
Snowberg, and Chassang (2016).
Here we offer some comments. First of all, implicitly many designs for randomized experi-
ments can be thought of as based on re-randomization. Consider the case where the population
of N = 100 individuals consists of 50 women and 50 men. Suppose we do a completely random-
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ized experiment, with 60 individuals to be assigned to the treatment group and the remaining
40 assigned to the control group. Now suppose we reject and re-randomize any randomization
vector that does not correspond to 30 men and 30 women being assigned to the treatment
group. Then, in an indirect manner, we end up with a stratified randomized experiment that we
know how to analyze, and that in general offers better sampling properties in terms of variance.
The point is that in this case the re-randomization does not create any complications, although
the appropriate analysis given the re-randomization is different from the one based on ignor-
ing the re-randomization. Specifically, p-values need to be adjusted for the re-randomization,
although ignoring the adjustment simply leads to conservative p-values. Both statements hold
more generally.
In order for the subsequent analysis to be able to take account of the re-randomization, how-
ever, the details of the re-randomization need to be spelled out. This is most easily seen if we con-
sider a Fisher exact p-value analysis. In order to calculate the exact p-value we need to know the
exact distribution of the assignment vector. In the case of possible re-randomization we would
therefore need to know exactly which assignment vectors would be subject to re-randomization,
and which would be viewed as acceptable. The actual criterion may be complicated, and involve
calculation of t-statistics for differences in average covariates between treatment groups, but it
needs to be completely spelled out in order for the exact p-value calculation to be feasible.
Doing this is ultimately equivalent to designing an experiment that guarantees more balance,
and it would most likely take a form close to that of a stratified randomized experiment. We
recommend simply taking care in the original design so that assignments that correspond to
unacceptable balance are ruled out from the outset, rather than ruled out ex post which com-
plicates inference.
8 The Analysis of Clustered Randomized Experiments
In this section we discuss clustered randomized experiments. Instead of assigning treatments
at the unit level, in this setting the population is first partitioned into a number of clusters.
Then all units in a cluster are then assigned to the same treatment level. Clusters may take
the form of schools, where within a school district a number of schools are randomly assigned
to an educational intervention rather than individual students, or villages, or states, or other
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geographical entities. For general discussions, see Donner (1987), Gail, Mark, Carroll, Green,
and Pee (1996), and Murray (2012).
Given a fixed sample size, this design is in general not as efficient as a completely randomized
design or a stratified randomized design. The motivation for such clustered designs is different.
One motivation is that in some cases there may be interference between units at the unit-level.
If there is no interference between units in different clusters, then the cluster-level randomization
may allow for simple, no-interference type analyses, whereas a unit-level analysis would require
accounting for the within-cluster interactions. A second motivation is that in many cases it
is easier to sample units at the cluster level. For the same cost, or level of effort, it may be
therefore be possible to collect data on a larger number of units.
In practice there are quite different settings where clustered randomization may take place.
In some cases the number of units per cluster is similar, for example in educational settings
where the clusters are classrooms. In other settings where clusters are geographical units, e.g.,
states, or towns, there may be a substantive amount of variation in cluster size. Although
theoretically this does not make much of a difference, in practice it can affect what effective
strategies are available for dealing with the clustering. In the first case our main recommendation
is to include analyses that are based on the cluster as the unit of analysis. Although more
sophisticated analyses may be more informative than simple analyses using the clusters as units,
it is rare that these differences in precision are substantial, and a cluster-based analysis has the
virtue of great transparency. Analyzing the data at the unit-level has the benefit that one
can directly take into account unit-level characteristics. In practice, however, including unit-
level characteristics generally improves precision by a relatively modest amount compared to
including cluster-averages as covariates in a cluster-level analysis, so our recommendation is
to focus primarily on cluster-level analyses. For the second case where there is substantial
variation in cluster sizes, a key component of our recommended strategy is to focus on analyses
with cluster-averages as the target in addition to analysis with unit-averages that may be the
main target of interest. The former may be much easier to estimate in settings with a substantial
amount of heterogeneity in cluster sizes.
8.1 The Choice of Estimand in Clustered Randomized Experiments
As before, let G be the number of clusters, and let Gig ∈ {0, 1}, i = 1, . . . , N , g = 1, . . . , G
denote the binary indicator that unit i belongs to cluster g. Ng =
∑N
i=1Gig is the number of
units in cluster g, so that Ng/N is the share of cluster g in the sample. Wi continues to denote
the treatment assignment for unit i, but now W g denotes the average value of the treatment
assignment for all units in cluster g, so that by the definition of clustered randomized assignment,
W g ∈ {0, 1}. Let Gt be the number of treated clusters, and Gc = G−Gt the number of control
clusters.
The first issue in clustered randomized experiments is that there may be different estimands
to consider. One natural estimand is the overall population average treatment effect,
τpop =
1
N
N∑
i=1
(
Yi(1)− Yi(0)
)
,
where we average over all units in the population. A second estimand is the unweighted average
of the within-cluster average effects:
τC =
1
G
G∑
g=1
τg, where τg =
1
Ng
∑
i:Cig=1
(
Yi(1)− Yi(0)
)
.
We can think of τC as a weighted average of the unit-level treatment effects, with the weight
for units in cluster g proportional to the inverse of the cluster sample size, 1/Ng. Similarly, the
population average treatment effect can be thought of as a weighted average of the cluster-level
average treatment effects with weights proportional to the cluster sample size Ng.
There are two issues regarding the choice of estimand. One is which of the estimands is
of most substantive interest. In many cases this will be the unweighted, population average
treatment effect τpop. A second issue is the ease and informativeness of any analysis. Because
the randomization is at the cluster level, simply aggregating unit-level outcomes to cluster-level
averages simplifies the analyis substantially: all the methods developed for completely random-
ized experiments apply directly to a cluster-level analysis for clustered randomized experiments.
In addition, inferences for τC are often much more precise than inferences for τpop in cases where
there are a few large clusters and many small clusters. Consider an extreme case where there
is one extremely large cluster, that in terms of size is larger then the other clusters combined.
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Inference for τpop in that case is difficult because all the units in this mega-cluster will always
be in the same treatment group. Inference for τC, on the other hand, may well be precise.
Moreoever, if the substantive question is one of testing for the presence of any treatment effect,
answering this question by focusing on a statistic that averages over clusters without weighting
is just as valid as comparing weighted averages over clusters.
In practice a researcher may therefore want to report analyses for τpop in combination with
analyses for τC. In cases where τpop is the estimand that is of most substantive interest, the
more precise inferences for τC may complement the noisy analyses for the substantively more
interesting τpop.
8.2 Point Estimation in Clustered Randomized Experiments
Now let us consider the analysis of cluster randomized experiments. We focus on the case where
unit-level outcomes and possibly covariates are available. The first choice facing the researcher
concerns the choice of the unit of analysis. One can analyze the data at the unit level or at the
cluster level. We first do the latter, and then return to the former.
If we are interested in the average effect τC, we can directly use the methods for completely
randomized experiments discussed in Section 4. Let Y
obs
g be the average of the observed outcomes
in cluster g. We can simply average the averages for the treated and control clusters:
τˆC =
1
Gt
∑
g:W g=1
Y
obs
g −
1
Gc
∑
g:W g=0
Y
obs
g .
The variance of this estimator can be estimated as
Vˆ(τˆC) =
s2
C,c
Gc
+
s2
C,t
Gt
,
where the variance for the averages of
s2
C,c =
1
Gc − 1
∑
g:W g=0
Y obsg − 1Gt ∑
g′:W g′=1
Y
obs
g′
2 ,
and similarly for s2
C,c. We can also get the same estimates using regression methods for the
regression function
Y
obs
g = α + τ
C ·W g + ηg. (8.1)
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We can generalize the specification of this regression function to include cluster-level covariates,
including cluster characteristics or averages of unit-level characteristics.
Using a unit-level analysis obtaining an estimate for τC is more complicated. Consider the
regression
Y obsi = α + τ ·Wi + εi. (8.2)
We can estimate this regression function using weighted least squares with the weight for unit i,
belonging to cluster g(i), equal to 1/Ng(i) as in the Cox (1956) analysis of weighted randomized
experiments. This weighted least squares estimator is identical to τˆC.
Now consider the case where we are interested in τpop. In that case we can estimate the
regression function in (8.2) without any weights. Alternatively, we can get the same numeri-
cal answer by estimating the regression (8.1) at the cluster level with weights proportional to
the cluster sample sizes Ng. To get the variance for the estimator for the population average
treatment effect we can use the unit-level regression, but we need to take into account the
clustering. We can do so using the robust clustering standard errors proposed by Liang and
Zeger (1986). Let αˆ and τˆ be the least squares estimators for α and τ based on (8.2), and let
εˆi = Y
obs
i − αˆ − τˆ ·Wi be the residual. Then the covariance matrix for (αˆ, τˆ ) can be estimated
as (
N∑
i=1
(
1 Wi
Wi Wi
))−1 G∑
g=1
∑
i:Cig=1
(
εˆi
Wi · εˆi
) ∑
i:Cig=1
(
εˆi
Wi · εˆi
)′( N∑
i=1
(
1 Wi
Wi Wi
))−1
.
The key difference with the Eicker-Huber-White robust standard errors is that before taking
the outer product of the product of the residuals and the covariates they are summed up within
clusters. This cluster-robust variance estimator is implemented in many regression software
packages, sometimes with ad hoc degrees of freedom adjustments.
If we compare unit-level and cluster-level analyses in the form described so far, our pref-
erence is for cluster-level analysis, as it is more transparent and more directly linked to the
randomization framework. However, unit-level analysis allows the analyst to impose additional
modeling assumptions; for example, a unit-level regression can incorporate covariates and im-
pose additional assumptions, such as restricting the effect of covariates to be common across
clusters. If justified, imposing such restrictions can increase efficiency. One could accomplish
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the same goal by first doing a unit-level regression and constructing residuals for each unit, and
then performing cluster-level analysis on the residuals, but at that point the inference would
become more complex and depart from the pure randomization-based analysis, reducing the
benefits of a cluster-based approach.
8.3 Clustered Sampling and Completely Randomized Experiments
A second issue related to clustering is that the original sample may have been obtained through
clustered sampling. This issue is discussed in more detail in Abadie, Athey, Imbens and
Wooldridge (2016). Suppose we have a large population. The population is divided into G
clusters, as in the previous discussion. Instead of a random sample from this population, we
first sample a number of clusters from the population of clusters. Within each of the sampled
clusters we sample a fixed fraction of the units within that cluster. Given our sample we conduct
a completely randomized experiment, without regard to the cluster these units belong to.
There is a subtle issue involved in defining what the estimand is. The first alternative is to
focus on the sample average treatment effect, that is, the average difference for the two potential
outcomes over all the units in the sample. A second alternative is to analyze the population
average treatment effect for all the units in the population, including those in non-sampled
clusters. For both alternatives, the simple difference in average outcomes by treatment status
is unbiased for the estimand.
Abadie, Athey, Imbens and Wooldridge (2016) show that we are interested in the sample
average treatment effect, we can ignore the clustering and use the conventional Neyman variance
estimator discussed in Section 4. In contrast, if we are interested in the population average
treatment effect, we need to take into account the implications of the clustering sampling design.
We can adjust the standard errors for the clustered sampling by using the Liang-Zeger (1986)
clustered standard errors.
9 Noncompliance in Randomized Experiments
Even if a randomized experiment is well designed, there may be complications in the implemen-
tation. One of the most common of these complications is non-compliance. Some units assigned
to the treatment group may end up not taking the treatment, and some units assigned to the
[46]
treatment group may manage to acquire the active treatment. If there are only violations of the
treatment assignment of the first type, we refer to it as one-sided non-compliance. This may
arise when individuals assigned to the control groups can be effectively be embargoed from the
active treatment. If some units assigned to the control group do manage to receive the active
treatment we have two-sided non-compliance.
The concern is that noncompliance is not random or accidental, but the result of systematic
differences in behavior or characteristics between units. Units who are assigned to the treatment
but who choose not receive it may do so because they are different from the units assigned to
the treatment who do receive it. These differences may be associated with the outcomes of
interest, thereby invalidating simple comparisons of outcomes by treatment received. In other
words, the randomization that validates comparisons by treatment status does not validate
comparisons by post-treatment variables such as the treatment received. These issues come up
both in randomized experiments as well as in observational studies. The general term for these
complications in the econometric literature is endogeneity of the receipt of treatment. Random
assignment ensures that the assignment to treatment is exogenous, but it does not bear on the
exogeneity of the receipt of treatment if the receipt of treatment is different from the assignment
to treatment.
In this chapter, we discuss three distinct approaches to dealing with non-compliance, all of
which are valid under fairly weak assumptions. First, one can ignore the actual receipt of the
treatment and focus on the causal effects of assignment to the treatment, in an intention-to-
treat analysis. Second, we can use instrumental variables methods to estimate the local average
treatment effect, the causal effect of the receipt of treatment for the subpopulation of compliers.
Third, we can use a partial identification or bounds analysis to obtain the range of values for the
average causal effect of the receipt of treatment for the full population. Another approach, not
further discussed here, is the randomization-based approach to instrumental variables developed
in Imbens and Rosenbaum (2005). There are also two types of analyses that require much
stronger assumptions in order to be valid. The first of these is an as-treated analysis, where
units are compared by the treatment received; this relies on an unconfoundedness or selection-
on-observables assumption. A second type of analysis is a per protocol analysis, where units are
dropped who do not receive the treatment they were assigned to.
We need some additional notation in this section. Let Zi ∈ {0, 1} denote the randomly
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assigned treatment. We generalize the notation for the treatment received, to reflect its status
as an (intermediate) outcome. Let Wi(z) ∈ {0, 1} denote the potential treatment outcome given
assignment z, withW obsi = Wi(Zi) the realized value for the treatment received. For the outcome
of primary interest, there are different set ups possible. One approach, e.g., Angrist, Imbens
and Rubin (1996), is to let Yi(z, w) denote the potential outcome corresponding to assignment
z and treatment received w. Alternatively, we could index the potential outcomes solely by the
assignment, with Y˜i(z) denoting the outcome corresponding to the treatment assigned to unit
i. The two notations are closely related, with Y˜i(z) = Yi(z,Wi(z)). Here we mainly use the first
set up. The realized outcome is Y obsi = Yi(Zi,Wi(Zi)) = Y˜i(Zi). To simplify notation, we index
sample sizes, averages, and variances by 0, 1 when they are indexed by values of the assignment
Zi, and by c, t when they are indexed by values of the treatment received Wi. For example, Y
obs
0,t
is the average of the observed outcome for units assigned to the control group (Zi = 0) but who
received the active treatment (W obsi = 1).
9.1 Intention-To-Treat Analyses
In an intention-to-treat analysis the receipt of treatment is ignored, and outcomes are compared
by the assignment to treatment (Imbens and Rubin, 2015; Fisher et al, 2000). The intention-
to-treat effect is the average effect of the assignment to treatment. In terms of the notation
introduced above, the estimand is
τ itt =
1
N
N∑
i=1
(
Yi(1,Wi(1))− Yi(0,Wi(0))
)
.
We can estimate this using the difference in averages of realized outcomes by treatment assign-
ment:
τˆ itt = Y
obs
1 − Y
obs
0 , where Y
obs
z =
1
Nz
∑
i:Zi=z
Y obsi for z = 0, 1.
To construct valid confidence intervals for τ itt we can use the standard methods discussed in
Section refsection:neyman. The exact variance for τˆ itt is
V
(
τˆ itt
)
=
S20
N0
+
S21
N1
− S
2
01
N
,
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where S20 and S
2
1 are the variances of Yi(0,Wi(0)) and Yi(1,Wi(1)) in the sample, defined as:
S20 =
1
N − 1
N∑
i=1
(
Yi(0,Wi(0))− Y (0)
)2
, and S21 =
1
N − 1
N∑
i=1
(
Yi(1,Wi(1))− Y (1)
)2
,
and S201 is the sample variance of the unit-level treatment effects, defined as:
S201 =
1
N − 1
N∑
i=1
(
Yi(1,Wi(1))− Yi(0,Wi(0))− (Y (1)− Y (0))
)2
.
We can estimate the first two terms as
s20 =
1
N0 − 1
∑
i:Zi=0
(
Yi(0,Wi(0))− Y obs0
)2
,
and
s21 =
1
N1 − 1
∑
i:Zi=1
(
Y obsi − Y 1
)2
.
As discussed in Section 4.2, the third term, S201 is generally impossible to estimate consistently
because we never observe both Yi(1,Wi(1)) and Yi(0,Wi(0)) for the same unit. In practice we
therefore use the estimator for V
(
τˆ itt
)
based on estimating the first two terms by s20 and s
2
1, and
ignoring the third term,
Vˆ(τˆ itt) =
s20
N0
+
s21
N1
.
This leads to valid confidence intervals in large samples, justified by the randomization and
sutva without additional assumptions.
The main drawback associated with the intention-to-treat approach is that the corresponding
estimand is typically not the object of primary interest. The researcher may be interested in
settings where the assignment mechanism may be different, and the incentives for individuals
to take the treatment might change. For example, in medical drug trials the compliance rate is
often very different from what would happen if a drug is released to the general population. In
the trial phase individuals, knowing that the efficacy of the drug has not been established, may
be more likely to stop adhering to the protocol. As a result the intention-to-treat effect would
not provide much guidance to the effects in the new setting. In other words, intention-to-treat
effects may have poor external validity. The presumption is that causal effects of the receipt of
treatment are more generalizable to other settings, though of course there is no formal result
that proves that this is so.
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9.2 Local Average Treatment Effects
An alternative approach that deals directly with the non-compliance is to use instrumental
variables methods and related methods based on principal stratification (Frangakis and Rubin,
2002; Barnard, Du, Hill, and Rubin, 1998). Bloom (1984), Zelen (1979, 1990), Baker and Lin-
deman (1994), Cuzick, Edwards, and Segnan (1997), contain early and independent discussions
of the instrumental variables approach, some in the special case of one-sided non-compliance,
and Imbens and Angrist (1994), Angrist, Imbens and Rubin (1996) develop the general set up
in the potential outcomes framework. See also Imbens and Rubin (2015) and Lui (2011) for
textbook discussions and Baker, Kramer, and Lindeman (2016) for a biostatistical perspective.
The first step is to consider the possible patterns of compliance behavior. Let Ci ∈ {c, d, a, n}
denote the compliance behavior, where
Ci =

c if Wi(0) = 0,Wi(1) = 1,
d if Wi(0) = 1,Wi(1) = 0,
a if Wi(0) = 1,Wi(1) = 1,
n if Wi(0) = 0,Wi(1) = 0,
where c stands for complier, d for defier, n for never-taker, and a for always-taker. These labels
are just definitional, not requiring any assumptions.
Now we consider two key assumptions. The first is monotonicity (Imbens and Angrist,
1994), or no-defiance, which requires
Wi(1) ≥ Wi(0).
This rules out the presence of defiers, units who always (that is, whether assignmed to control
or treatment), do the opposite of their assignment. In the setting we consider in this chapter,
where the instrument is the random assignment to treatment, this appears a very plausible
assumption: assigning someone to the active treatment increases the incentive to take the active
treatment, and it would appear unusal for there to be many units who would respond to this
increase in incentives by declining to take the treatment where they would otherwise have done
so. In other settings monotonicity may be a more controversial assumption. For example, in
studies in criminal justice researchers have used random assignment of cases to judges to identify
the causal effect of prison terms on recidivism (reference). In that case even if one judge is more
strict than another in the sense that the first judge has a higher rate of sentencing individuals
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to prison terms, it is not necessarily the case that any individual who would be sentenced to
time in prison by the on-average more lenient judge would also be sentenced to prison by the
stricter judge.
The second key assumption is generally referred to as the exclusion restriction. It requires
that there is no direct effect of the assignment on the outcome without passing through the
receipt of treatment. Formally, using the form used in Angrist, Imbens and Rubin (1996),
Yi(z, w) = Yi(z
′, w), for all z, z′, w.
The key components on the assumption is that for never-takers,
Yi(0, 0) = Yi(1, 0), and for always− takers Yi(0, 1) = Yi(1, 1).
For compliers and defiers the assumption is essentially about the interpretation of the causal
effect of the assignment to treatment to the causal effect of the receipt of treatment. The
exclusion restriction is a strong one, and its plausibility needs to be argued on a case-by-case
basis. It is not justified by, and in fact not related to, the random assignment. Given the
exclusion restriction we can drop the dependence of the potential outcomes on z, and simply
write Yi(w), for w = 0, 1.
Given the monotonicity assumption and the exclusion restriction we can identify the average
causal effect of the receipt of treatment on the outcome, what is known as the local average
treatment effect (Imbens and Angrist, 1994):
τ late = E[Yi(1)− Yi(0)|Ci = c] = E[Y
obs
i |Zi = 1]− E[Y obsi |Zi = 0]
E[W obsi |Zi = 1]− E[W obsi |Zi = 0]
.
Given the setting it is clear that we cannot identify the average effect for always-takers or neve-
takers without additional assumptions: we do not observe outcomes for always-takers without
the receipt of treatment, and we do not observe outcomes for never-takers given receipt of
treatment. As a result we need assumptions to extrapolate the treatment effects for compliers
to other compliance groups in order to identify the overall average treatment effect.
9.3 Generalizing the Local Average Treatment Effect
One major concern with the local average treatment effect is that it reflects only on a sub-
population, the compliers. In many cases the researcher may be more interested in the overall
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average effect of the treatment. Here we discuss some supplementary analyses that can be done
to assess the generalizability of the local average treatment effect. This section builds on the
discussions in Angrist (2004), Hirano, Imbens, Rubin, and Zhou (2000), Imbens and Rubin
(1997ab) and Bertanha and Imbens (2014). The Bertanha and Imbens (2015) discussion is pri-
marily in the context of fuzzy regression discontinuity designs, but their results apply directly
to other instrumental variables settings.
We use the same set up as in the previous section, but explicitly allow for the presence of
exogenous covariates Xi. Instead of using instrumental variables methods to estimate the local
average treatment effect an alternative approach is to adjust for differences in the covariate to
estimate the average effect of the treatment, assuming unconfoundedness:
Wi ⊥⊥
(
Yi(0), Yi(1)
) ∣∣∣ Xi.
If this assumption is valid, we can estimate the average effect of the treatment, as well as average
effects for any subpopulation using an as-treated analysis. One natural analysis is to compare
the local average treatment effect to the covariate-adjusted difference by treatment status. A
formal comparison of the two estimates, in a linear model setting, would be a Hausman test
(Hausman, 1983). In the absence of covariates the Hausman test would be testing the equality
pia
pia + pic · pz ·
(
E[Yi(1)|Gi = a]− E[Yi(1)|Gi = c]
)
=
pin
pin + pic · (1− pz) ·
(
E[Yi(0)|Gi = n]− E[Yi(0)|Gi = c]
)
,
where pia, pic, and pin are the population shares of always-takers, compliers, and never-takers
respectively. This equality is difficult to interpret. A particular weighted average of the difference
between the expected outcomes given treatment for always-takers and compliers is equal to
a weighted average of the difference between the expected outcomes without treatment for
compliers and never-takers.
Compared to the Hausman test a more natural and interpretable approach is to test the
equality of the unweighted differences, between always-takers and treated compliers and never-
takers and not-treated compliers,
E[Yi(1)|Gi = a]− E[Yi(1)|Gi = c] = E[Yi(0)|Gi = n]− E[Yi(0)|Gi = c],
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as suggested in Angrist (2004).
Bertanha and Imbens suggest testing the pair of equalities, rather than just the difference,
E[Yi(1)|Gi = a]− E[Yi(1)|Gi = c] = 0, and E[Yi(0)|Gi = n]− E[Yi(0)|Gi = c] = 0.
If this pair of equalities hold, possibly after adjusting for differences in the covariates, it means
that always-takers are comparable to compliers given the treatment, and never-takers are com-
parable to compliers without the treatment. That would suggest that always-takers without the
treatment might also be comparable to compliers without the treatment, and that never-takers
with the treatment might be comparable to compliers with the treatment, although neither claim
can be tested. If those equalities were to hold, however, then the average effect for compliers,
adjusted for covariates, can be generalized to the entire population.
9.4 Bounds
To get estimates of, or do inference for, the average causal effect of the receipt of treatment in
settings with non-compliance an alternative to making additional assumptions, is to focus on
getting ranges of values for the estimand that are consistent with the data in a bounds or partial
identification approach in a line of research associated with Manski (1990, 1996, 2003, 2013).
The simplest approach without any additional assumptions recognizes that because of the
non-compliance the receipt of treatment is no longer exogenous. We can therefore analyze this
as an observational study without any assumptions on the assignment process. Consider the
average difference in potential outcomes if all units are assigned to the treatment versus no-one
is assigned to the treatment,
τ =
1
N
N∑
i=1
(
Yi(1)− Yi(0)
)
= Y (1)− Y (0).
To estimate this object it is useful to look at both terms separately. The first term is
Y (t) =
Nt
N
· Y obst +
Nc
N
· 1
Nt
∑
i:Wi=0
Yi(1).
The last term is what is causing the problems. The data are not directly informative about this
term. Let us look at the special case where the outcome is binary. In that case
Y (t) ∈
[Nt
N
· Y obst ,
Nt
N
· Y obst +
Nt
N
]
.
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We can do the same thing for the second term in the estimand, leading to
τ ∈
[Nt
N
· Y obst −
Nc
N
· Y obsc −
Nc
N
,
Nt
N
· Y obst +
Nt
N
− Nc
N
· Y obsc
]
.
This is not a very informative range. By construction it always includes zero, so we can never
be sure that the treatment has any effect on the outcome of interest.
Next, let us consider how the bounds change when we add information in the form of ad-
ditional assumptions. Under the full set of instrumental variables assumptions, that is, the
monotonicity assumption and the exclusion restriction, we can tighten the bounds substantially.
To derive the bounds, and at the same time develop intuition for their value, it is useful to
think of the average treatment effect as the sum of the averages over the three compliance
groups, compliers, never-takers and always-takers, with shares equal to pic, pin, and pia, respec-
tively. Under monotonicity and the exclusion restriction the average effect for compliers is
identified. For always-takers we can identify E[Yi(1)|Ci = a], but the data are uninformative
about E[Yi(0)|Ci = a], so that the average effect for always-takers is bounded by
τa ∈
[
E[Y obsi |Zi = 0,Wi = 1]− 1, ,E[Y obsi |Zi = 0,Wi = 1]
]
.
Similarly,
τn ∈
[
−E[Y obsi |Zi = 1,Wi = 0], , 1− E[Y obsi |Zi = 1,Wi = 0]
]
.
Combining these leads to
τ ∈
[
pia ·
(
E[Y obsi |Zi = 0,Wi = 1]− 1
)− τn · E[Y obsi |Zi = 1,Wi = 0]
+
(
E[Y obsi |Zi = 1]− E[Y obsi |Zi = 1]
)
,
pia · E[Y obsi |Zi = 0,Wi = 1] + pin ·
(
1− E[Y obsi |Zi = 1,Wi = 0]
)
+
(
E[Y obsi |Zi = 1]− E[Y obsi |Zi = 1]
)]
.
Under these assumptions these bounds are sharp (Balke and Pearl, 1997).
9.5 As-Treated and Per Protocol Analises
There are two older methods that have sometimes been used to analyze experiments with non-
compliance that rely on strong assumptions, as-treated and per-protocol analyses. See, for
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example, McNamee (2009) and Imbens and Rubin (2015). In an as-treated analysis units are
compared by the treatment received, rather than the treatment assigned, essentially invoking
an unconfoundedness assumption. Because it was the assignment that was randomized, rather
than the receipt of treatment, this is not justified by the randomization. It is useful to consider
in a setting where the instrumental variables assumptions, that is, the monotonicity assumption
and the exclusion restriction, hold, and assess what the as-treated analysis leads to.
The estimand in an as-treated analysis is
τ at = E[Y obsi |Wi = 1]− E[Y obsi |Wi = 0].
If the monotonicity assumption holds the first term is an average of outcomes given treatment
for always-takers and compliers. If the fraction of units with Zi = 1 is equal to pZ , then we can
write the first term as
E[Y obsi |Wi = 1] =
pia
pia + pic · PZ · E[Yi(1)|Ci = a] +
pic · pZ
pia + pic · PZ · E[Yi(1)|Ci = c].
Similarly,
E[Y obsi |Wi = 0] =
pin
pin + pic · (1− PZ) ·E[Yi(0)|Ci = n] +
pic · (1− pZ)
pin + pic · (1− PZ) ·E[Yi(0)|Ci = c].
The difference is then
E[Y obsi |Wi = 1]− E[Y obsi |Wi = 0]
= E[Yi(1)− Yi(0)|Ci = c]
+
pia
pia + pic · PZ ·
(
E[Yi(1)|Gi = a]− E[Yi(1)|Ci = c]
)
− pin
pin + pic · (1− PZ) ·
(
E[Yi(0)|Gi = n]− E[Yi(0)|Ci = c]
)
.
This last two terms in expression are compared to zero in a Hausman test for the exogeneity of
the treatment. The form is in general difficult to interpret.
The second is a per protocol analysis, where units who do not comply with their assigned
treatment are simply dropped from the analysis. Again it is instructive to see what this method
is estimating under the monotonicity assumption and the exclusion restriction. In general,
τpp = E[Y obsi |Wi = 1, Zi = 1]− E[Y obsi |Wi = 0, Zi = 0].
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Similar calculations as for the as-treated analysis show that given monotoniticy and the exclusion
restriction this is equal to
τpp = E[Yi(1)− Yi(0)|Ci = c] + pia
pia + pic
·
(
E[Yi(1)|Gi = a]− E[Yi(1)|Ci = c]
)
− pin
pin + pic
·
(
E[Yi(0)|Gi = n]− E[Yi(0)|Ci = c]
)
.
This expression is again dificult to interpret in general, and the analysis is not recommended.
10 Heterogenous Treatment Effects and Pretreatment Vari-
ables
Most of the literature has focused on estimating average treatment effects for the entire sample
or population. However, in many cases researchers are also interested in the presence or absence
of heterogeneity in treatment effects. There are different ways to study such heterogeneity. Here
we discuss some approaches. Note that this is different from the way covariates or pretreatment
variables were used in Section 4.4, where the focus remained on the overall average treatment
effect and the presence of pretreatment variables served solely to improve precision of the esti-
mators. In observational studies covariates also serve to make the identifying assumptions more
credible.
As discussed at the outset of this chapter, a key concern with randomized experiments is
external validity. If we apply the treatment in a different setting, will the effect be the same?
Although there are many factors that vary across settings, one common way that settings differ
is that the populations of individual units may be different. If these differences can be captured
with observable pre-treatment variables, then it is in principle possible to address this element of
external validity as in Hotz, Imbens and Mortimer (2005). In particular, if we obtain an estimate
of the treatment effect for each potential value of the covariate vector x, then we can estimate
average treatment effects in any population be accounting for the differences in distributions.
That is, given an estimate for τ(x) = E[Yi(1)− Yi(0)|Xi = x], it is straightforward to estimate
E[τ(Xi)] if the distribution of Xi is known.
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10.1 Randomized Experiments with Pretreatment Variables
Traditionally researchers specified particular subpopulations based on substantive interest, and
estimated average treatment effects for those subpopulations, as well as tested equality of treat-
ment effects across these subpopulations. For example, one may be interested separately in the
effect of an educational progam on girls versus boys. In such cases the analyses are straight-
forward. One can simply analyze the data separately by subpopulation using the methods
developed in Section 6.1. In these cases there is often some concern that the subpopulations
were selected ex post, so that p-values are no longer valid because of multiple testing concerns.
For example, suppose one has a randomized experiment, with a hundred independent binary
pretreatment variables that are in fact unrelated to the treatments or the outcomes. One would
expect that for five of them the t-statistic for testing the null hypothesis that the average treat-
ment effect was different by the value of that covariate was larger than 2 in absolute value, even
though none of the covariates are related to the treatment effect. Pre-analysis plans (Casey,
Glennerster, and Miguel, 2012; Olken, 2015) are one approach to alleviate such concerns; another
is to correct for multiple testing (List, Shaikh, and Xu, 2016). Below we describe some recently
developed alternatives that work not only when the number of covariates is small, but also when
the number is large relative to the sample size or the true underlying model of treatment effect
heterogeneity may be quite complex.
10.2 Testing for Treatment Effect Heterogeneity
A second approach is to simply test for the presence of heterogeneity in the average treatment
effect as a function of the covariates, τ(x) = E[Yi(1)− Yi(0)|Xi = x].
One type of test considers whether there is any evidence for observable heterogeneity. Crump,
Hotz, Imbens and Mitnik (2008) develop nonparametric tests for the null hypothesis
H0 : τ(x) = τ, for all x ∈ X,
against the alternative
H0 : τ(x) 6= τ(x′), for some x, x′ ∈ X.
The Crump et al set up uses a sequence of parametric approximations to the conditional expec-
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tation
E[Y obsi |Wi = w,Xi = x] = β ′0h(x) · (1− w) + β ′1h(x) · w,
for vector-valued functions h(x) and then tests the null hypothesis the equality β1 = β0. By
increasing the dimension of h(x), with a suitable basis of functions, one can nonparametrically
test the null hypothesis that the average treatment effect τ(x) is constant as a function of
the covariates under the assumption of unconfoundedness, which is implied by randomized
assignment.
A researcher might also like to understand which, if any, covariates are associated with
treatment effect. A natural approach would be to evaluate heterogeneity with respect to each
covariate, one by one. For example, each covariate could be transformed into a binary indicator
for whether the value of the covariate is above or below the median, and then the researcher
could test the hypothesis that the treatment effect is higher when the covariate is high than when
it is low. Conducting a large number of hypothesis tests raises issues of multiple testing, and
confidence intervals should be be corrected to account for this. However, standard approaches
(e.g. the Bonferroni correction) assume that each test is independent, and thus may be overly
conservative in an environment where many covariates are correlated with one another (which
will imply that the test statistics are also correlated with one another). List, Shaikh, and
Xu (2016) propose a computationally feasible approach to the multiple testing problem in this
context. The approach uses bootstrapping, and it accounts for correlation among test statistics.
One challenge with this approach is that the researcher must pre-specify the set of hypothesis
tests to conduct; thus, it is hard to explore all possible interactions among covariates and all
possible ways to discretize them. In the next section, we consider methods that explore more
complex forms of heterogeneity.
10.3 Estimating Treatment Effect Heterogeneity
There are several possible approaches for exploring treatment effect heterogeneity. The first
is to specify a parametric model of treatment effect heterogeneity (as in (5.4)) and report the
estimates. For example, one simple approach would be to specify a regression of the outcome
on an indicator for treatment status as well as interactions of the indicator with the treatment
indicator. With a small number of covariates relative to the sample size, all linear interactions
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with the treatment indicator could be considered, partially alleviating concerns about multiple
testing. Below we discuss generalizations of this idea to regularized regression (e.g. LASSO)
where a systematic method is used to select covariates.
A second approach is to construct a fully nonparametric estimator for τ(x). We will develop
this approach further below; with sufficiently large datasets and a relatively small number of
covariates, this approach can be effective, and recent work building on techniques from machine
learning (Wager and Athey, 2015) has lead to improvements in how many covariates can be
handled without sacrificing coverage of confidence intervals. For the case where there may be
many covariates relative to the sample size, a third approach proposed by Athey and Imbens
(2015) uses the data to select a set of subgroups (a “partition” of the covariate space) such that
treatment effect heterogeneity across subgroups is maximized in a particular sense.
Whether a fully non-parametric approach or an approach based on subgroups is preferred
may be partially determined by the constraints of the data; valid confidence intervals may not
be available (at least with existing methods) with too many covariates relative to sample size.
But even if both methods are potentially feasible, it may be desirable to learn about subgroups
rather than a fully nonparametric estimate of τ(x) if the results of the experiment will be used in
a context where people with limited processing capability/memory will make decisions based on
the experiment. For example, doctors might use a simple flowchart to determine which patients
should be prescribed a drug. Results about subgroups may also be more easily interpretable by
researchers.
Relative to testing all covariates one by one, an approach that selects a single partition of
the covariate space will not in general discover all heterogeneity that exists, since the algorithm
will focus on the covariates with the biggest impact to the exclusion of others. In addition, in
the process of constructing a partition, once we have divided the data into two groups according
to the value of one covariate, further divisions will be considered on subsamples of the data,
reducing the power available to test heterogeneity in additional covariates. Thus, constructing
a single partition does not answer the question of which covariates are associated with hetero-
geneity; rather, it identifies a particular way to divide the data into meaningful groups. If a
researcher wanted to explore all covariates, while maintaining a data-driven approach to how to
discretize them, an approach would be to construct distinct partitions that restrict attention to
one covariate at the time. For interactions, one could consider small subsets of covariates. If
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the results of such an exercise were reported in terms of which covariates are associated with
significant heterogeneity, multiple testing corrections would be warranted. The approach of List,
Shaikh, and Xu (2016) works for an arbitrary set of null hypotheses, so the researcher could
generate a long list of hypotheses using the causal tree approach restricted to different subsets
of covariates, and then test them with a correction for multiple testing. Since in datasets with
many covariates, there are often many ways to describe what are essentially the same sub-
groups, we expect a lot of correlation in test statistics, reducing the magnitude of the correction
for multiple hypothesis testing.
We begin by describing the third approach, where we construct a partition of the covariate
space, and then return to the second and first approaches.
10.3.1 Data-driven Subgroup Analysis: Recursive Partitioning for Treatment Ef-
fects
Athey and Imbens (2016) develop a method for exploring heterogeneity in treatment effects
without having to prespecify the form of the heterogeneity, and without having to worry about
multiple testing. Their approach builds on “regression tree” or “recursive partitioning” methods,
where the sample is partitioned in a number of subgroups, defined by the region of the covariate
space each unit belongs to. The data is used to determine which partition produces subgroups
that differ the most in terms of treatment effects. The method avoids introducing biases in
the estimated average treatment effects and allows for valid confidence intervals using “sample
splitting,” or “honest” estimation. The idea of sample splitting to control significance levels goes
back a long way in statistics; see, e.g. Cox (1975), or for a more recent discussion, see Fithian,
Sun, and Taylor (2015). In a sample splitting approach, in a first step, one sample is used to
select the partition, while in a second step an independent sample is used to estimate treatment
effects and construct confidence intervals for each subgroup (separately) given the partition from
the first step. The output of the method is a set of subgroups, selected to optimize for treatment
effect heterogeneity (to minimize expected mean-squared error of treatment effects), together
with treatment effect estimates and standard errors for each subgroup.
Let us illustrate some of the issues in a simple case to develop more intuition. Suppose we
consider only a single split of the covariate space, in a setting with a substantial number of
covariates. We specify a criterion that determines whether one split (that is, a combination
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of a choice of the covariate and a threshold) is better than another. We return to the choice
of criterion below. Given a criterion, we select the covariate and threshold that maximize the
citerion. If we estimate the average treatment effect on the two subsamples using the same
sample, the fact that this particular split led to a high value of the criterion would often imply
that the average treatment effect estimate is biased. Athey and Imbens (2016) therefore suggest,
in what they call an honest approach, to estimate the treatment effects on a separate sample.
The implication is that the treatment effect estimates are unbiased on the two subsamples,
and the corresponding confidence intervals are valid, even in settings with a large number of
pretreatment variables or covariates.
A key issue is the choice of criterion. In principle one would like to split in order to obtain
more precise estimates of the average treatment effects. A complicating factor is that the
standard criterion for splitting optimized for prediction rely on observing the outcome whose
expectation one wants to estimate. That is not the case here because the unit-level treatment
effect is not observed. There have been various suggestions in the literature to deal with this.
One simple solution is to transform the outcome from Y obsi to
Y ∗i = Y
obs
i ·
Wi − p
p · (1− p) .
This transformed outcome has the property that E[Y ∗i |Xi = x] = τ(x) = E[Yi(1)−Yi(0)|Xi = x]
so that standard methods for recursive partitioning based on prediction apply (see Weisberg
and Pontes (2015), Athey and Imbens (2016)). Su et al (2009) suggest using test statistics for
the null hypothesis that the average treatment effect in the two subsamples are equal to zero.
Zeileis, Hothorn, and Hornick (2008) suggest using model fit, where the model corresponds to
a linear regression model in the partitions with an intercept and a binary treatment indicator.1
Athey and Imbens (2016) show that neither of the two criteria is optimal, and derive a new
criterion that focuses directly on the expected squared error of the treatment effect estimator,
and which turns out to depend both on the t-statistic and on the fit measures. The criterion
is further modified to anticipate honest estimation, that is, to anticipate that the treatment
effects will be re-estimated on an independent sample after the subgroups are selected. This
modification ends up penalizing the expected variance of subgroup estimates; for example, if
1Neither of those two papers consider honest estimation, nor do they establish bias and consistency properties
of the estimators.
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subgroups are too small, the variance of treatment effect estimates will be large. It also rewards
splits for covariates that explain outcomes but not treatment effect heterogeneity, to the extent
that controlling for such covariates enables a lower-variance estimate of the treatment effect.
Other related approaches include Wager and Walther (2015), who discuss corrections to
confidence intervals (widening the confidence intervals by a factor) as an alternative to sample
splitting; however, since confidence intervals need to be inflated fairly substantially, it is not clear
whether there is a wide range of conditions where it improves on sample splitting. Relative to
the approach of List, Shaikh, and Xu (2016) discussed above, the methods in this section focus
on deriving a single partition, rather than considering heterogeneity one covariate at the time
with pre-specified discretizations of the covariates; the approaches in this section will have the
advantage of exploring interaction effects and using the data to determine a meaningful partition
in terms of mean-squared error of treatment effects.
10.3.2 Non-Parametric Estimation of Treatment Effect Heterogeneity
There are (at least) four possible goals for using non-parametric estimation to estimate hetero-
geneous treatment effects. The first is descriptive: the researcher can gain insight about what
types of units have the highest and lowest treatment effects, as well as visualize comparative
statics results, all without imposing a prior restrictions. The second, disucssed earlier, is that
the researcher wishes to estimate the impact of applying the treatment in a setting with a
different distribution of units. A third is that the researcher wishes to derive a personalized
policy recommendation. A fourth is that the researcher wishes to test hypotheses and construct
confidence intervals. If confidence intervals are desired, the set of potential methods is quite
small. For optimal policy evaluation, a Bayesian framework may have some advantages, since
it is natural to incorporate the uncertainty and risk involved in alternative policy assignments.
For description or estimation where confidence intervals are not important, there are a wide
variety of approaches.
Classical non-parametric approaches to treatment effect heterogeneity would include K-
nearest neighbor matching and kernel estimation (Ha¨rdle, 2002). In the case of K−nearest
neighbor matching, for any x we can construct an estimate of the treatment effect at that x
by averaging the outcomes of the K nearest neighbors that were treated, and subtracting the
average outcomes of the K nearest neighbors that were control observations. Kernel estimation
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does something similar, but uses a smooth weighting function rather than uniformly weighting
nearby neighbors and giving 0 weight to neighbors that are farther away. In both cases, distance
is measured using Euclidean distance for the covariate vector. These methods can work well and
provide satisfactory coverage of confidence intervals with one or two covariates, but performance
deteriorates quickly after that. The output of the nonparametric estimator is a treatment effect
for an arbitrary x. The estimates generally must be further summarized or visualized since the
model produces a distinct prediction for each x.
A key problem with kernels and nearest neighbor matching is that all covariates are treated
symmetrically; if one unit is close to another in 20 dimensions, the units are probably not par-
ticularly similar in any given dimension. We would ideally like to prioritize dimensions that
are most important for heterogeneous treatment effects, as is done in many machine learning
methods, including the highly successful random forest algorithm. Unfortunately, many popular
machine learning methods that use the data to select covariates may be bias-dominated asymp-
totically (including the standard random forest). Recently, Wager and Athey (2015) propose a
modified version of the random forest algorithm that produces treatment effect estimates that
can be shown to be asymptotically normal and centered on the true value of the treatment
effect, and they propose a consistent estimator for the asymptotic variance. The method aver-
ages over many “trees” of the form developed in Athey and Imbens (2016); the trees differ from
one another because different subsamples are used for each tree, and in addition there is some
randomization in the choice of which covariates to split on. Each tree is “honest,” in that one
subsample is used to determine a partition and an independent subsample is used to estimate
treatment effects within the leaves. Unlike the case of a single tree, no data is “wasted” because
each observation is used to determine the partition in some trees and used to estimate treatment
effects in other trees, and subsampling is already an inherent part of the method. The method
can be understood as a generalization of kernels and nearest neighbor matching methods, in
that the estimated treatment effect at x is the difference between a weighted average of nearby
treated units and nearby control units; but the choice of what dimenions are important for
measuring distance is determined by the data. In simulations, this method can obtain nominal
coverage with more covariates than K-Nearest Neighbour matching or kernel methods, while
simultaneously producing much more accurate estimates of treatment effects. However, this
method also eventually becomes bias-dominated when the number of covariates grows. It is
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much more robust to irrelevant covariates than kernels or nearest neighbor matching.
Another approach to the problem is to divide the training data by treatment status, and
apply supervised learning methods to each group separately. For example, Foster, Taylor, and
Ruberg (2011) use random forests to estimate the effect of covariates on outcomes in treated
and control groups. They then take the difference in predictions as data and project treatment
effects onto units’ attributes using regression or classification trees. The approach of Wager
and Athey (2015) can potentially gain efficiency by directly estimating heterogeneity in causal
effects, and further the off-the-shelf random forest estimator does not have established statistical
properties (so confidence intervals are not available).
Taking the Bayesian perspective, Green and Kern (2012) and Hill (2011) have proposed the
use of forest-based algorithms for estimating heterogeneous treatment effects. These papers
use the Bayesian additive regression tree method of Chipman et al (2010), and report posterior
credible intervals obtained by Markov-chain Monte Carlo sampling based on a convenience prior.
Although Bayesian regression trees are often successful in practice, there are currently no results
guaranteeing posterior concentration around the true conditional mean function, or convergence
of the Markov-Chain-Monte-Carlo sampler in polynomial time. In a related paper, Taddy,
Gardner, Chen and Draper (2014) use Bayesian nonparametric methods with Dirichlet priors to
flexibly estimate the data-generating process, and then project the estimates of heterogeneous
treatment effects down onto the feature space using regularization methods or regression trees
to get low-dimensional summaries of the heterogeneity; but again, asymptotic properties are
unknown.
10.3.3 Treatment Effect Heterogeneity Using Regularized Regression
Imai and Ratkovic (2013), Signorovitch (2007), Tian et al (2014), and Weisberg and Pontes
(2015) develop lasso-like methods for causal inference and treatment effect heterogeneity in a
setting where there are potentially a large number of covariates, so that regularization methods
to discover which covariates are important. When the treatment effect interactions of interest
have low dimension (that is, a small number of covariates have important interactions with
the treatment), valid confidence intervals can be derived (without using sample splitting as
described above); see, e.g., Chernozhukov, Hansen, and Spindler (2015) and references therein.
These methods require that the true underlying model is (at least approximately) “sparse”: the
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number of observations must be large relative to the number of covariates (and their interactions)
that have an important effect on the outcome and on treatment effect heterogeneity. Some of the
methods (e.g. Tian et al (2014)) propose modeling heterogeneity in the treatment and control
groups separately, and then taking the difference; this can be inefficient if the covariates that
affect the level of outcomes are distinct from those that affect treatment effect heterogeneity. An
alternative approach is to incorporate interactions of the treatment with covariates as covariates,
and then allow LASSO to select which covariates are important. Interaction terms can be
prioritized over terms that do not include treatment effect interactions through weighting.
10.3.4 Comparison of Methods
Although the LASSO based methods require more a priori restrictions on sparsity than the
random forest methods, both types of methods will lose nominal coverage rates if the models
become too complex. The LASSO methods have some advantages with datasets where there are
linear or polynomial relationships between covariates and outcomes; random forest methods do
not parsimoniously estimate linear relationships and use them for extrapolation, but are more
localized. The random forest methods are well-designed to capture complex, multi-dimensional
interactions among covariates, or highly nonlinear interactions. LASSO has the advantage that
the final output is a regression, which may be more familiar to researchers in some disciplines;
however, it is important to remember that the conditions the justify the standard errors are
much more stringent when the model selection was carried out on the same data that is used for
estimation. If valid confidence intervals are the first priority in an environment where the model
is not known to be sparse and there are many covariates, the recursive partitioning approach
provides confidence intervals that do not deteriorate (at all) as the number of covariates grow.
What suffers, instead, is the mean-squared error of the predictions of treatment effects.
Another point of comparison between the regression-based methods and tree-based meth-
ods (including random forests) relates to our earlier discussions of randomization-based infer-
ence versus sampling-based inference. Tree-based methods construct estimates by dividing the
sample into subgroups and calculating sample averages within the groups; thus, the estimates
and associated inference can be justified by random assignment of the treatment. In contrast,
regression-based approaches require additional assumptions.
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10.3.5 Relationship to Optimal Policy Estimation
The problem of estimating heterogeneous treatment effects is closely related to the problem
of estimating, as a function of the covariates, what the optimal policy is. Heuristically, with
a binary treatment, we would want to assign an individual with covariates x to a treatment
if τ(x) > 0. However, the optimal policy literature addresses additional issues that might
arise when there are multiple potential treatments, as well as when the loss function may be
nonlinear (so that there is, for example, a mean-variance tradeoff between different policies).
More broadly, the criterion used in estimation may be modified to account for the goal of
policy estimation; when regularization approaches are used to penalize model complexity, the
methods may de-prioritize discovering heterogeneity that is not relevant for selecting an optimal
policy. For example, if a treatment clearly dominates another for some parts of the covariate
space, understanding heterogeneity in the magnitude of the treatment’s advantage may not be
important in those regions.
Much of the policy estimation literature takes a Bayesian perspective; this allows the re-
searcher to evaluate welfare and to incorporate risk aversion in the loss function in an environ-
ment where there is uncertainty about the effects of the policy.
In the machine learning literature, Beygelzimer and Langford (2009) and Dudik, Langford
and Li (2011) discuss procedures for transforming outcomes that enable off-the-shelf loss min-
imization methods to be used for optimal treatment policy estimation. In the econometrics
literature, Graham, Imbens and Ridder (2014), Dehejia (2005), Hirano and Porter (2009), Man-
ski (2004), and Bhattacharya and Dupas (2012) estimate parametric or semi-parametric models
for optimal policies, relying on regularization for covariate selection in the case of Bhattacharya
and Dupas (2012). See also Banerjee, Chassang and Snowberg (2015).
11 Experiments in Settings with Interactions
In this section we discuss the analysis of randomized experiments in settings with interference
between units. Such interference may take different forms. There may be spillovers from the
treatment assigned to one unit to other units. A classic example of that is that of agricultural
experiments where fertilize applied to one plot of land may leach over to other plots and thus
affect outcomes in plots assigned to different treatments. It may also take the form of active and
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deliberate interactions between individuals, for example in educational settings, where exposing
one student to a new program may well affect the outcomes for students the first student is
friends with.
There are many different versions of these problems, and many different estimands. An
important theoretical paper in an observational setting is Manski (1993) who introduced ter-
minology to distinguish between contextual effects, exogenous effects, and endogenous effects.
Contextual effects arise when individuals are exposed to similar environmental stimula as their
peers. Exogenous effects refer to effects from fixed characteristics of an individual’s peers. En-
dogenous effects in Manski’s terminology refer to direct causal effects of the behavior of the
peers of an individual.
The interactions may be a nuisance that affects the ability to do inference, with the interest
in the overall average effect, or the interactions may be of primary interest to the researcher.
This is an active area of research, with many different approaches, where it it not clear what will
ultimately be the most useful results for empirical work. In fact, some of the most interesting
work has been empirical.
11.1 Empirical Work on Interactions
Here we discuss some of the questions raised in empirical work on interactions. These provide
some of the background for the discussions of the theoretical work by suggesting particular
questions and settings where these questions are of interest. There are a number of different
settings. In some cases the peer group composition is randomized, and in other cases treatments
are randomized. An example of the first case is Sacerdote (2001) where individual students are
randomly assigned to dorm rooms and thus matched to a roommate. An example of the second
is Duflo and Saez (2003) where individuals in possibly endogenously formed groups are randomly
assigned to treatments, with the treatments clustered at the group level.
Miguel and Kremer (2004) were interested in the effects of deworming programs on children’s
educational outcomes. There are obviously direct effects of deworming on the outcomes for
individuals who are exposed to these programs, but just as in the case of infectious diseases
in general, there may be externalities for individuals not exposed to the program if individuals
they interact with are exposed. Miguel and Kremer find evidence of substantial externalities.
Crepon et al (2013) were interested in the effects of labor market training programs. They
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were concerned about interactions between individuals through the labor market. Part of the
effect of providing training to an unemployed individual may be that this individual becomes
more attractive to an employer relative to an untrained individual. If, however, the total number
of vacancies is not affected by the presence of more trained individuals, the overall effect may be
zero even if the trained individuals are more likely to be employed than the individuals in the
control group. Cre´pon et al studied this by randomizing individuals to training programs in a
number of labor markets. They varied the marginal rate at which the individuals were assigned to
the training program between the labor markets. They then compared the difference in average
outcomes by treatment status within the labor markets, across the different labor markets. In
the absence of interactions, here in the form of equilibrium effects, the average treatment effects
should not vary by the marginal treatment rate. Evidence that the average treatment effects
were higher when the marginal treatment rate was lower suggests that part of the treatment
effect was based on redistributing jobs from control individuals to trained individuals.
Sacerdote (2001) studies the effect of roommates on an individual’s behavior in college. He
exploits the random assignment of incoming students to dorm rooms at Dartmouth (after taking
account of some characteristics such as smoking behavior). The treatment can be thought of
here as having a roommate of a particular type, such as a roommate with a relatively high or
low level of high school achievement. If roommates are randomly assigned, then finding that
individuals with high achieving roommates have outcomes that are systematically different from
those of individuals with low achieving roommates is evidence of causal interactions between
the roommates.
Carrell, Sacerdote and West (2013) analyze data from the US Air Force Academy. They
control the assignment of incoming students to squadrons to manipulate the distribution of
characteristics of fellow squadron students that an incoming student is faced with. They find
that the outcomes for students vary systematically with this distribution of fellow student char-
acteristics, which is evidence of causal effects of interactions.
11.2 The Analysis of Randomized Experiments with Interactions in
Subpopulations
One important special case of interference assumes the population can be partitioned into groups
or clusters, with the interactions limited to units within the same cluster. This is a case studied
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by, among others, Manski (2013) and Hudgens and Halloran (2008), and Liu and Hudgens (2013).
Ugander, Karrer, Backstrom and Kleinberg (2013) discuss graph cutting methods in general
network settings to generate partitions of the basic network where such an assumption holds,
at least approximately. Hudgens and Halloran define in this setting direct, indirect, total and
overall causal effects, and consider a two-stage randomized design where in the first stage clusters
are selected randomly and in the second stage units within the clusters are randomly assigned.
The direct causal effect for a particular unit corresponds to the difference between potential
outcomes where only the treatment effect for that unit is changed, and all other treatment are
kept fixed. Indirect effects correspond to causal effects of changes in the assignments for other
units in the same group, keeping fixed the own assignment. The total effect combines the direct
and indirect effects. Finally, the overall effect in the Hudgens and Halloran framework is the
average effect for a cluster or group, compared to the baseline where the entire group receives
the control treatment.
Hudgens and Halloran also stress the widely used assumption that for unit i it matters only
what fraction of the other units in their group are treated, not the identity of the treated units.
Without such an assumption the proliferation of indirect treatment effects makes it difficult
to obtain unbiased estimators for any of them. This assumption is often made, sometimes
implicitly, in empirical work in this area.
They consider designs where the marginal rate of treatment varies across groups. In the first
stage of the assignment the groups are randomly assigned to different treatment rates, followed
by a stage in which the units are randomly assigned to the treatment.
11.3 The Analysis of Randomized Experiments with Interactions in
Networks
Here we look at a general network setting where the population of units is not necessarily
partitioned into mutually exclusive groups. With N individuals in the population of interest
we have a network characterized by an N × N adjacency matrix G, with Gij ∈ {0, 1} a binary
indicator for the event that units i and j are connected. The matrix G is symmetric with
all diagonal elements equal to zero. The question here is what we can learn about presence
interaction effects by conducting a randomized experiment on this single network, with a binary
treatment. Unlike the Manski (1993) and Hudgens and Halloran (2008) setting, we have only a
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single network, but the network is richer in the sense that it need not be the case that friends
of friends are also friends themselves. The type of questions Athey, Eckles and Imbens (2015)
are interested in are, for example, whether there is evidence that changing the treatment for
friends affects an individual’s outcome, or whether manipulating treatments for friends of an
individual’s friends changes there outcome. They do so by focusing on exact tests to avoid
the reliance on large sample approximations, which can be difficult to derive in settings with a
single network. (There is not even a clear answer to the question of what it means for a network
to grow in size; specifying this would require the researcher to specify what it means for the
network to grow, in terms of new links for new units.)
Let us focus in this discussion on the two main hypotheses Athey, Eckles and Imbens (2015)
consider. First, the null hypothesis of no interactions whatsoever, that is the null hypothesis
that changing the treatment status for friends does not change an individual’s outcome, also
considered in Aronow (2012), and second, the null hypothesis that the treatment of a friend of
a friend does not have a causal effect on an individual’s outcome. Like Liu and Hudgens (2013)
and Athey, Eckles and Imbens (2015), they consider randomization inference.
We focus on the setting where in the population treatments are completely randomly as-
signed. The network itself is analyzed as given. Initially let us focus on the null hypothesis of no
interactions whatsoever. Athey, Eckles and Imbens (2015) introduce the notion of an articifial
experiment. The idea is to select a number of units from the original population, whom they
call the focal units. Given these focal units they define a test statistic in terms of the outcomes
for these focal units, say the correlation between outcomes and the fraction of treated friends.
They look at the distribution of this statistic, induced by randomizing the treatments only for
the non-focal or auxiliary units. Under the null hypothesis of no treatment effects whatsoever,
changing the treatment status for auxiliary units would not change the value of the outcomes
for the focal units.
For the second null hypothesis, that friends of friends have no effect, they again consider a
subset of the units to be focal. A second subset of units are termed “buffer” units: these are
the friends of the focal unit. If we allow that friends can have an impact on focal units, then
their treatments cannot be randomized in the artificial experiment designed to test the impact
of friends of friends. The complement of focal and buffer units, termed the auxiliary units,
are the units whose treatments are randomized in the artificial experiment. The randomization
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distribution over the treatment assignments of auxiliary units induces a distribution on the test
statistic, and this approach thus enables the researcher to test the hypothesis that friends of
friends have no effect, without placing any restrictions on direct effects or the effect of friends.
Athey, Eckles and Imbens (2015) also consider richer hypotheses, such as hypotheses about
what types of link definitions correspond to meaningful peer effects; they propose a test of the
hypothesis that a sparser definition of the network is sufficient to capture relationships for which
treating a friend influences a unit.
Aronow and Samii (2013) study estimation in this general network setting. They assume
that there is a structure on the treatment effects so that only a limited number of unit-level
treatment assignments have a non-zero causal effect on the outcome for unit i. The group
structure that Hudgens and Halloran (2008) use is a special case where it is only the treatments
for units in the same group as unit i can have non-zero effects on the outcome for unit i.
12 Conclusion
In this chapter we discuss statistical methods for analyzing data from randomized experiments.
We focus primarily on randomization-based, rather than model-based methods, starting with
classic methods developed by Fisher and Neyman, up to recent work on non-compliance, cluster-
ing and methods for identifying treatment effect heterogeneity, as well as experiments in settings
with interference.
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